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Resumo
Atualmente existe uma crescente incidência de doenças no mundo e por isso, existe uma maior
quantidade de medicamentos disponíveis para promover uma maior eficiência nos sistemas de
saúde. Assim, a importância dos novos medicamentos é indiscutível para a vida humana e, conse-
quentemente traduz-se numa maior competência a nível profissional, trazendo muitos benefícios
para a sociedade em geral. Por acréscimo, o seu uso consciente conduz também a uma decrescente
necessidade de outros cuidados de saúde mais prolongados e de custos mais elevados.
Os fármacos desencadeiam um efeito terapêutico que proporciona uma melhoria de qualidade
de vida, no entanto, para sintetizar um fármaco novo, a indústria farmacêutica tem que percorrer
um longo, complexo e oneroso processo.
Um dos problemas de saúde que tem vindo a crescer exponencialmente corresponde às doenças
neurodegenerativas. Este crescimento veio então aumentar a necessidade de descobrir e desen-
volver novos fármacos que possam combater este problema. O processo de conceção de fármacos
para este tipo de doenças, em que o fármaco tem que alcançar o Sistema Nervoso Central (SNC),
é ainda mais demorado devido à complexidade do cérebro, à tendência dos fármacos para provo-
carem efeitos adversos graves e principalmente devido à existência da Barreira Hemato-Encefálica
(BHE).
O processo de conceção de fármacos é constituído por diversas etapas até atingir a fase final
que corresponde aos testes clínicos. Uma das fases do processo testa cinco propriedades impor-
tantes de um medicamento, conhecida como fase dos testes ADMET (Absorção, Distribuição,
Metabolismo, Excreção e Toxicidade). Estes testes são geralmente muito dispendiosos pois são
efetuados em animais.
Com base no historial dos testes ADMET e informação sobre a estrutura e propriedades da
molécula do princípio ativo de um fármaco, a informática pode dar um importante contributo para
atenuar o problema dos custos elevados e do tempo gasto no processo de desenho de fármacos.
Um dos pontos em que o Data Mining pode ser relevante é em evitar ou reduzir a fase em que as
moléculas mais promissoras são testadas em animais, ou seja, com base nos resultados anteriores,
o Data Mining pode ser utilizado para prever que moléculas vão apresentar resultados mais viáveis.
O trabalho desta dissertação consiste no estudo de técnicas de Data Mining e avaliação das
suas potencialidades para melhorar o processo de desenvolvimento de novos fármacos, e sobretudo
contribuir para o melhoramento e redução dos custos dos testes ADMET.
Particularmente, consiste na utilização de dois conjuntos de dados: dados com informação
sobre a toxicidade das moléculas e dados com informação sobre moléculas que conseguem ultra-
passar a Barreira Hemato-Encefálica.
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Abstract
Currently there is an increasing incidence of diseases in the world and therefore, there is a greater
quantity of medicines available to promote a greater efficiency in the health systems.
Thus, the importance of new medicines is indisputable for human life and, consequently trans-
lates into greater professional competence, bringing many benefits to society. In addition, its
conscious use also leads to a decreasing need for other, longer and more expensive health care.
Drugs trigger a therapeutic effect that provides an improvement in quality of life. However, to
synthesize a new drug, the pharmaceutical industry has to go through a long, complex and costly
process.
One of the health problems that has been growing exponentially corresponds to neurodegen-
erative diseases. This growth increased the need to discover and develop new drugs that could
counteract this problem. The drug design process for this type of disease, in which the drug has
to achieve the Central Nervous System (CNS), is even more time-consuming due to the complex-
ity of the brain, the tendency of the drugs to cause serious adverse effects and mainly due to the
existence of the Blood-Brain Barrier (BBB).
The process of drug design consists of several steps until reaching the final phase that corre-
sponds to the clinical tests. One of the process steps consists on testing five important properties of
a drug, known as ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) tests.
These tests are usually very expensive because they are done on animals.
Based on the ADMET tests historical and information on the structure and properties of a
drug’s active principle molecule, Informatics can make an important contribution to alleviating
the problem of high costs and time spent in the drug design process. One of the points in which
Data Mining may be relevant is to avoid or reduce the phase where the most promising molecules
are tested on animals. Based on the previous results, Data Mining can be used to predict which
molecules are going to present more viable results.
The work of this dissertation consists of the study of Data Mining techniques and evaluation of
its potentialities to improve the process of development of new drugs, and above all to contribute
to the improvement and reduction of the costs of ADMET tests. In particular, it consists of the use
of two data sets: data with information about the toxicity of molecules and data with information
on molecules that can overcome the Blood-Brain Barrier.
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Chapter 1
Introduction
In this chapter, a context for the work is provided, the domain problem is identified and the main
goals of the dissertation are specified.
1.1 Contextualization
In recent years, an enormous number of drugs has contributed to an increase in efficiency in health
systems, promoting an improvement in quality of life of the population and also a decrease in the
mortality rate.
Drugs are molecules that when introduced into the human body produce a therapeutic effect.
However, the impact of drugs use causes some controversy in society. On the one hand, drugs may
increase the average life time expectancy of people and allow curing some diseases leading to an
improved quality of life. On the other hand, they can increase health-care costs if used incorrectly,
and also lead to adverse effects [1].
The discovery of new drugs is related to scientific and technological innovations. The major
advances in some areas such as chemistry and biology, and a better understanding of targets and
molecular mechanisms that lead to the onset of diseases, have made possible the discovery of
remarkable therapeutic formulations [1].
One drawback of the design of new drugs is that it is a process highly complex, long (about
five to twelve years) and costly [1]. When the process refers to the design of drugs for the Central
Nervous System (CNS), it can take even longer (up to 16 years).
Regarding the success rate of the drugs for CNS being approved, the percentage is much lower,
about 8%, while drugs for the cardiovascular system, for example, have a success rate of 20%1.
Furthermore, the discovery of new drugs is not always achieved. Normally the main cause
for that is the lack of efficacy, the existence of toxicity in preclinical trials and any uncertainty
in clinical trials [5]. Rational Drug Design (RDD) is an interdisciplinary process that requires
the collaboration of researchers with very different skills [6]. RDD aims at a fast and cheap
1Alzheimer’s Drug Discovery Foundation. Available in www.alzdiscovery.org/, accessed last time in 22-11-
2016
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development of new drugs and can strongly benefit from two research areas: Chemoinformatics
and Knowledge Discovery in Databases (KDD)2.
With the advancing of times, technologies using computers play a crucial role in all health-
related areas. The increase of technological knowledge leads to greater development in this area.
Although Informatics tools can be quite useful in more than one step of the drug design process,
the focus of the study will be the contribution that Informatics, and Data Mining specifically, can
do to the ADMET tests phase.
There are currently several computational methods to predict drug efficacy. These predictive
tests help health care providers in choosing the best drug for each situation, and may avoid future
problems and adverse effects in patients. With the use of these tools, the time required for the drug
development process decreases substantially.
Data Mining uses historical data to construct predictive models. Since the amount of drug
design related data in the Internet has increased at a very large pace in the last years, those data
repositories can be used to improve KDD.
1.2 Objectives
The main goal of this dissertation is the use of Chemoinformatics and Data Mining tools in order
to help in the KDD process which will lead to a reduction in time and cost of the development
of new drugs. The approach adopted in this study is directed to a testing phase, in the process of
development of new drugs, related to toxicity (ADMET tests) and is also directed to molecules
behaviour for Blood-Brain Barrier penetration. Thus, several key points have to be studied and
addressed.
In the first part of this project, the main objectives are to understand the basic concepts of
drugs, molecular descriptors and their tools, and the overall process of RDD. Secondly, the goal is
to explore the concepts of Data Mining tasks and tools, and describe some related work.
After this research, it is essential to investigate and explore Data Mining tools for predicting
drug efficacy. The purpose is to use DM techniques in a simplified way to construct models to
predict drug efficacy, in order to reduce the time spent designing a new drug.
Thus, it is extremely necessary to address the following two research questions:
H1. Is DM useful to improve the drug design process?
H2. Can we provide extra domain knowledge to improve the DM construct model?
The answer to these questions is debated in the conclusions of the work in Chapter 5.
2KDD is a several step data analysis process, one of which is Data Mining (DM), where models are constructed.
Since Data Mining is one of the most important steps, KDD is often referred to as DM. From now on it will be used
DM to refer to both the model construction step and the KDD process as a whole.
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1.3 Dissertation structure
This report is divided into five chapters. This first chapter presents a general approach and contex-
tualization of the theme, as well as the main goals of the work.
Chapter 2 introduces the basic concepts related to the state of art of the domain: drugs, molec-
ular descriptors and Chemoinformatics tools. In that chapter are also explained several concepts
concerning the RDD process, Data Mining algorithms, methodologies and tasks, and ontologies.
In Chapter 3 is presented the project implementation from the data preparation to the processes
and algorithms used.
Chapter 4 describes the experiences, results achieved and some conclusions of these.
Finally, the conclusions and future work are presented in Chapter 5.
4 Introduction
Chapter 2
State of art
This chapter introduces the reader to the state of the art of the domain of our study. It addresses the
essential topics related development of new drugs and Chemoinformatics. It presents the overall
process of Rational Drug Design (RDD), a description of the state of the art of the Data Mining
and related work on the topic of the dissertation. A set of relevant concepts concerning ontologies
are also described.
2.1 Development of new drugs
2.1.1 Basic concepts
Since ancient times, people seek in nature resources to relieve and treat the diseases that arise. In
early days, therapeutic resources used were derived from plants and animals, among others. Later
on, the search for active principles1 of plants to create the first drugs2 improved matters3. Most
drugs that are used in modern medicine, are the result of the progress achieved since the second
world war in the field of synthetic organic chemistry and biotechnology4. The process of research
and drug development has undergone several changes over time with the advances in molecular
biology. A drug is defined as any substance other than food or an artefact, which is used for
diagnosis, alleviation, treatment and cure of diseases, as well as for the prevention of them4. It
can be defined as a chemical that interacts with a body part, to change an existing physiological or
biochemical process, and may decrease or increase the function of an organ, tissue or cell, but it
does not create new functions4, [1].
1An active principle is defined as the constituent of a drug that is widely responsible for conferring pharmacological
effect. Different drugs may have the same active principle.
2The concept of drug and medicine sometimes is confused. However, these are different concepts, since the medicine
is the final product containing the active ingredient (drug), presented in various pharmaceutical forms (capsule, liquid,
among others.)
3"Conceitos gerais sobre medicamentos".Available in www.anvisa.gov.br/hotsite/genericos/
profissionais/conceitos.htm, accessed last time in 25-10-2016
4"Generalidades sobre os fármacos".Available in www.manuaismsd.pt/?id=31, accessed last time in 25-10-
2016
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Drugs classification
There are several criteria to classify drugs as is possible to see in Figure 2.1. They can be classified
according to:
Origin
i) Natural source: inorganic, animal, vegetable (more prevalent).
ii) Synthetic source.
iii) Intermediate: corresponding to products of fermentation and genetic engineering.
Action mode
i) Etiological drugs: treat the cause of a disease; almost all belong to the class of chemothera-
peutics used to treat infections and parasitic diseases.
ii) Replacement drugs: to overcome for the deficiency of a substance; this deficiency may be
due to poor diet, or physiological disorders; substitution treatment may be temporary or perma-
nent.
iii) Symptomatic drugs: alleviate the symptoms of a disease; they are used to attenuate or
neutralize disorders resulting from a pathological condition.
Nature of the disease: classification adopted by World Health Organization (WHO) that dis-
tinguishes the drugs by the organ in the body which they operate.
Chemical structure: allows for screening drugs analogs derived from the same compound,
which facilitates the establishment of correlations between structure and activity5.
Figure 2.1: Schematic representation of possible criteria to classify drugs. Adapted from5.
5"Classificação de fármacos".Available in https:fenix.tecnico.ulisboa.pt/downloadFile/
3779571315641/c, accessed last time in 25-10-2016
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2.1.2 Rational Drug Design
Drugs are used since ancient times for catalyzing chemical changes in the human body and for its
development. With the widespread use of computers, a new approach for drug design emerged.
Rational Drug Design (RDD) is the process of creating new drugs with the aid of computa-
tional methods. This design is based on information about chemical structures for computationally
aided analysis and identification of chemical groups that are drug candidates [1].
Over time, drug design has been evolving into more organized processes that become crucial,
and new techniques have been tested and used accordingly. After being made a market survey
on the disease to be treated, the second step consists in identifying the biological target. The
knowledge of the biological target is essential for drug design, because the developed molecules
must comply with some minimal structural characteristics to bind to the active regions of the final
target. Then it is important to identify the cellular localization of the target at the level of the cell
membrane or intracellular. The initial prototype can be found in two distinct ways: based on the
binder, that is, when there is prior knowledge of molecules that bind to the desired biological target
molecule; and based on the structure, which means that, by methods such as x-ray crystallography
or Nuclear Magnetic Resonance (NMR) spectroscopy, the three-dimensional structure of the target
is known6, [7].
The design of the drug structure will depend on the organ it will act, so there are some struc-
tural requirements. In addition to bind to the target, the drug must be able to interact with it so, a
further step designated by screening, is required.
In the screening phase, different biological assays in molecular, cellular and organic levels, are
made to define the activity and selectivity of the future drug candidate.
After these steps, the drug candidates that successfully surpass the screening procedures must
be optimized. This optimization can be done by increasing the degree of activity, increasing the
selectivity and passing successfully the tests of Absorption, Distribution, Metabolism, Excretion
and Toxicology (called ADMET) [1].
One of the major problems with the ingestion of certain drugs is their side effects. Instead
of binding to the biological target as intended, drugs can do the same with other undesirable
molecules and then trigger chemicals processes which are not important for the treatment of dis-
ease and may even raise other problems. So, it is important to reach a prototype with high selec-
tivity, whose activity is reduced to the undesirable molecules [1].
The next step is to conduct ADMET tests in animals to assess each of the characteristics.
The last stages of the drug design process are the clinical trials. These are conducted in humans
and aim to strengthen the results about the safety of the drug, the recommended dosage and its
effectiveness [1].
These clinical studies can be divided into four distinct phases:
6Biopharmaceutical Research Development.Available in http://phrma-docs.phrma.org/sites/
default/files/pdf/rd_brochure_022307.pdf, accessed last time in 18-10-2016
8 State of art
Phase I: the main objective of this phase is to evaluate the tolerance in humans and the recom-
mended dosage. The patients are monitored for 24 hours, because the purpose is to evaluate
the effect of the first dose.
Phase II: this phase aims to study the therapeutic efficacy of the dose range, the kinetics and
metabolism.
Phase III: is intended to test the efficacy and safety over a large number of samples, which
means, increasing the diversity of people in the tests. The studied drug is administered to a
patient sample as similar as possible to the intended population after marketing.
Phase IV: as phase III, this phase aims to test the effectiveness and safety through a high number
of samples. After the sale, the drug continues to be studied by pharmacovigilance, which
aims to obtain information on their effects, their interactions with other medications and
assess their safety. This phase belongs to the responsibility of the regulatory organization
and corresponds to the drug study used in the medical practice [1].
Figure 2.2 summarizes all process of development of new drugs.
Figure 2.2: Different steps of the development of new drugs. Adapted from [1].
ADMET tests
The human body has many defence mechanisms to expel foreign bodies and to protect it from
viruses, infections, etc. The five features of ADMET tests must be understood in order to develop
a successful drug [1].
Absorption determines the ability of a compound to overcome the barriers of the human body
and reach the target tissue or organ.
Distribution of a drug is usually through the bloodstream, and therefore, the effect of the
drug on the target is related to plasma concentration. Different tissues and organs have different
absorption capacities and do not have the same rate of blood flow. So, distribution determines the
amount of drug which is administered.
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Metabolism consists in enzymatic reactions to which the compounds are subject when they
enter the organism. These reactions can be hydrolysis- that will inactivate the compound or make
it more soluble- or oxidation/reduction reactions that will alter the chemical structure of the com-
pound.
Excretion is the elimination of metabolites (resulting from the breakdown of molecules enter-
ing the body) through urine, faeces or sweat.
Finally, the toxicity is the degree of damage that the drug can cause to the organism [1].
Drug design and the Blood-Brain Barrier
Designing drugs to act within the brain is a special case of the design process. The drug design
process was already explained, but when referring to Central Nervous System (CNS) drugs, the
success rate is much lower. This low rate has several causes, such as, the high degree of complexity
of the brain, the problem of the side effects that drugs can cause in the CNS and the presence of
the Blood-Brain Barrier (BBB) [8].
Blood-Brain Barrier is a highly selective permeable structure that protects the CNS7. This bar-
rier consists of endothelial cells that form capillaries in the brain, and limits the entry of molecules
due to the tight junctions formed by transmembrane proteins, negative polarity of the surface and
the high level of efflux transporters. The tight junctions significantly reduce the permeation of ions
and other small hydrophilic solutes through intercellular gap (paracellular route), thereby forming
the physical barrier [9]. This barrier is a vital element in regulating the stability of the internal
environment of the brain [10]. Thus, the BBB is very important for the CNS connection to periph-
eral tissues, and acts as an interface that limits and regulates the exchange of substances between
the CNS and the blood. Apart from the selective permeability functions that protect the CNS from
damage, BBB has other functions such as providing a stable environment in neural function and
maintaining an optimal ionic composition for synaptic signalling function by junction specific ion
channels and transporters. The BBB also helps to maintain the separation between the central and
peripheral transmitters, thereby reducing their communication [11, 12, 13].
This barrier excludes from the brain all large molecules and 98% of small-molecules of drugs
[14]. Only small molecules with high solubility in lipid and a molecular weight of less than 400-
500 Daltons can cross the BBB. Unfortunately, only a few brain diseases respond favorably to
these drugs. Another problem of small molecules is that only a low percentage of them can cross
the BBB in sufficient pharmacological quantities [15].
Drugs that are specific to the CNS must first cross the BBB. The clarification of drug transport
mechanisms across the Blood Brain Barrier is important for improving the effectiveness of drugs
into the CNS and reducing their toxicity [2, 16, 17].
The transport mechanisms through the BBB can occur in five ways and are represented in
Figure 2.3.
7"Barreira hematoencefálica".Available in www.oncoguia.org.br/conteudo/
o-que-e-a-barreira-hematoencefalica/5720/773/, accessed last time in 25-10-2016
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Figure 2.3: Five transport routes through BBB. Extracted from [2].
One of these routes of transport (represented by letter ’a’ in the figure), is the paracellular
and it corresponds to the diffusion of the polar solutes by the tight junctions.
Represented by letter ’b’ is transcelular lipophilic. This route represents the passive diffusion
of lipid soluble agents and is related to some properties of the molecules.
The third route corresponds to the transport proteins (represented by letter ’c’). These pro-
teins are in the endothelium and correspond to the entry of various nutrients and endogenous
compounds.
Another pathway is receptor-mediated transcytosis (represented by letter ’d’ in the figure).
It corresponds to the transport to the brain of some proteins, such as, insulin and transferrin.
Represented by letter ’e’, the fifth route is adsorptive transcytosis. There are native plasma
proteins that are surrounded by positive charges, in order to increase the transport through this
pathway.
BBB is very protective in nature. Thus, the inability of molecules of a drug to penetrate it is a
significant impediment for the CNS drug candidates and must be taken into consideration early in
the drug design process. This can be changed by an effort to develop knowledge concerning the
BBB transport properties and molecular and cellular biology of the capillary endothelium of the
brain. However, even if some pharmaceutical company decides to develop a BBB program there
are few scientists with knowledge on the subject [2, 9, 14, 16].
2.2 Molecular descriptors
The properties of a molecule contain all of the essential chemical information about it. However,
only part of this information is extracted from experimental measurements, as the properties of a
molecule do not result from the sum of the properties of its components. Due to this complexity,
molecular structures cannot be represented by a single formal model. Thus, various molecular
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representations exist that can represent the same molecule8, 9. Therefore, to facilitate this repre-
sentation molecular descriptors were introduced. Molecular descriptors are designed to assist in
the drug study process10.
V. Consonni and R. Todeschini8 describe a molecular descriptor as "the final result of a logic
and mathematical procedure which transforms chemical information encoded within a symbolic
representation of a molecule into a useful number or the result of some standardized experiment."
Thus, a molecular descriptor is the numerical description of some property of the molecule.
These numbers represent various parts of the chemical information contained in different molec-
ular representations. These descriptors are usually used to establish quantitative relationships
between structure and properties, and biological activities11.
Currently, molecular descriptors play an essential role in scientific research, as can be seen in
Figure 2.4.
Figure 2.4: Representation of molecular descriptors origin, processing and applications. Adapted
from 10.
A proof of the interest of the scientific community by molecular descriptors is the number of
descriptors that exist today. About 2000 descriptors are defined and can be calculated using spe-
cific software. The different descriptors are distinguished by the complexity of the encoding infor-
mation and the time required for calculation. Generally, computational requirements increase with
what degree of discrimination is achieved, for example, the molecular weight does not transmit
8What is a molecular descriptor, Viviana Consonni and Roberto Todeschini, 2000.Available in www.
moleculardescriptors.eu/tutorials/T1_moleculardescriptors_what_is.pdf, accessed last time
in 25-10-2016
9Molecular descriptors: An introduction, 2006. Available in http://infochim.u-strasbg.fr/CS3/
program/material/Todeschini.pdf, accessed last time in 24-11-2016
10Molecular descriptors and chemometrics: a powerful combined tool for pharmaceutical, toxicologi-
cal and environmental problems, Roberto Todeschini.Available in www.iamc-online.org/tutorials/T2_
moleculardescriptors_chemom.pdf, accessed last time in 25-10-2016
11An integrated web-based platform for molecular descriptor and fingerprint computation, March, 2015. Available
in www.scbdd.com/chemdes/, accessed last time in 17-10-2016
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much on the properties of a molecule but is very quick to compute, while the quantum mechanics
can provide accurate representations of properties but take longer time to be calculated [18, 19].
There are several types of molecular descriptors:
3D descriptors: depend on the internal coordinates or absolute orientation of the molecule. 3D
descriptors encode several aspects of the three-dimensional structure of the molecule. These
descriptors are used in many studies because of the relevance that accompanies the relation-
ship between the ligand conformation and its bioactivity;
2D descriptors: represent descriptors of single value calculated from the graph of the molecule
and characterize the structures according to the size, degree of branching and the shape of
the overall molecule;
0D and 1D descriptors: are very general, fast to calculate, and therefore do not describe suffi-
ciently the molecule;
fingerprints: are a particular and complex type of molecular descriptors that represent the molec-
ular structures and properties of molecules. These features are usually encoded as binary bit
vectors, whose purpose is to reproduce (in several different ways), a characteristic pattern
of the given molecule12, [19, 20, 21, 22].
Chemoinformatics tools and data files formats
Chemoinformatics tools are quite valuable since they help to speed up and automate a lot of im-
portant tasks of the RDD process. In this project were only used tools to compute molecular
descriptors and tools to convert among data formats.
Tools for the calculation of molecular descriptors can transform chemical information which
is encoded into a symbolic representation of the numbers in the molecule, or receive files with the
chemical information of molecules and calculate the molecular descriptors.
Currently, the available tools to calculate molecular descriptors and for data conversion are:
PaDEL Descriptor is an open source software used for the calculation of molecular descrip-
tors and fingerprints. Through the chemical formula of a given substance, this software is able to
translate it into mathematical values, which provide detailed information about the substance to be
explored. It has the ability to calculate 1875 descriptors (1444 descriptors (1D, 2D) and 431 3D
descriptors) and 12 types of fingerprints. It is a program developed using the Java13 language and
consists of a library and an interface component14.
OpenBabel is a chemoinformatics tool designed to read various chemical data formats. It
is an open source software. It can be used for several purposes, such as, filtering, conversion,
12"Descritores moleculares para aprendizagem automática".Available in http://joao.airesdesousa.com/
agregacao/slides_2013/descritores_QSPR_slides.pdf, accessed last time in 24-11-2016
13Java is a programming language and computing platform.
14Padel-descriptor, 2014.Available in www.yapcwsoft.com/dd/padeldescriptor/, accessed last time in 25-
10-2016
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analysis and storage of molecular modeling data. This tool is commonly used for the proliferation
of multiple formats of chemical files, since it has the capacity to convert about 110 formats15, [23].
PowerMV is a software used for statistical analysis, molecular viewing, calculation of de-
scriptors and similar researches. It supports files in SDF format and properties of molecules can
be exported to Excel to generate custom reports16.
MODEL (Molecular Descriptor Lab) is a software that allows the calculation of structural
and physico-chemical properties of molecules from its 3D structure [24].
JOELib is a software used for the chemical conversion of file formats. It is a chemoinformat-
ics library programmed in Java and has an interface with external programs17.
Visual Molecular Dynamics (VMD) is a computer program used for molecular analysis and
for the analysis of large biomolecular systems using 3D graphics and embedded scripts. This
program allows a modeling and analysis of several biological systems, such as proteins. VMD
is very easy to use and run on MacOS X, Unix and Windows [25]. There is no limit on number
of molecules or atoms viewed, supports more than 60 molecular file formats and has extensive
documental support18.
These tools support files in various formats19.
Structure Data Format (SDF) belongs to the chemical data file formats developed by Molecular
Design Limited (MDL). It is a chemical file format used to represent chemical structures and has
the interesting feature of allowing the inclusion of extra associated data. Due to its characteristics,
it is the most widely used standard for importing and exporting information on chemical data20.
Another format commonly used for molecule notation is the Simplified Molecular Input Line
Entry Specification (SMILES). In this language there are two main types of symbols, atoms and
bonds. This format has the advantage of presenting the information in an understandable and very
compact way21. The SMARTS format is used to match chemical file substructures, using rules
that are direct extensions of SMILES22.
Chemical Markup Language (CML) acts as a support for chemical substances, such as molecules,
and also for reactions, spectros, analytical data, among others. Manages molecular information
using Extensible Markup Language (XML)23 and Java languages. This format has the advantage
15Open babel:The open source chemistry toolbox, 2011.Available in http://openbabel.org/wiki/Main_
Page, accessed last time in 12-10-2016
16Powermv.Available in www.niss.org/research/software/powermv, accessed last time in 25-10-2016
17Joelib/joelib2.Available in https://sourceforge.net/projects/joelib/, accessed last time in 25-10-
2016
18VMD program.Available in www.ks.uiuc.edu/Research/vmd/, accessed last time in 20-01-2017
19There are, currently, around 100 file formats for chemoinformatics data.
20How to create SD/SDF files.Available in https://eurl-ecvam.jrc.ec.europa.eu/
laboratories-research/predictive_toxicology/qsar_tools/qrf/How_to_create_SDF_files.
pdf, accessed last time in 18-11-2016
21SMI file extension.Available in www.file-extensions.org/smi-file-extension-daylight-smiles-file,
accessed last time in 18-11-2016
22SMARTS - A Language for Describing Molecular Patterns.Available in www.daylight.com/dayhtml/doc/
theory/theory.smarts.html, accessed last time in 18-11-2016
23XML is a language that defines a set of rules for encoding documents in a format that can be understood by humans
and machines.
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of using XML portability to help interoperate documents between the various entities of interest24.
International Chemical Identifier (InChI) is a text identifier for chemicals. It is used to stan-
dardize the coding of molecular information and to facilitate the search of this information, thus
allowing an easier connection between the various data collections. This format was developed
during a project of the International Union of Pure and Applied Chemistry (IUPAC)25.
Web repositories
There are many web repositories with available databases storing drugs efficacy tests. Some of
them allow public access, others have a cost.
Distributed Structure-Searchable Toxicity (DSSTox) is a project that belongs to the Com-
putational Toxicology Research Program of the United States Environmental Protection Agency.
It is a repository that provides a fairly complete chemical resource, which contains toxicity data
present on certain molecules and chemical structures26. This database is free, so it can be con-
sulted by the general public, thus promoting research and development. The format of this data is
the SDF, already explained above27.
US Food and Drug Administration (FDA) is a well-known regulatory agency of drugs that
is responsible for ensuring the safety and efficacy of drugs in order to preserve the health of
population. It has an open source database online28.
Pre-clinical And Clinical Trials knowledge base on bioavailability (PACT-F) is a database
structure-based and consists of the results of human clinical trials and pre-clinical animal tests.
PACT-F exists since 2005 and is currently the largest bioavailability database in the world and
contains approximately 8296 clinical trial registrations. These records are described in detail on-
line and contain the chemical structure of the various compounds, thus allowing scientists to relate
this structure to bioavailability. PACT-F contains all the important information for the development
of predictive models that will allow to study the bioavailability of the new compounds. PACT-F
is a database that allows the development of computational models, selection of candidate drugs
based on previous assays, exploring the various factors that affect bioavailability, identifying some
structural patterns that may influence bioavailability and drug optimization29.
The National Library of Medicine (NLM) TOXNET is a free web repository, managed
by the Toxicology and Environmental Health Information Program (TEHIP), which contains a
group of databases related to chemicals, pharmaceuticals, general health and also toxicology. This
repository can be used to search for chemical nomenclatures, chemicals, chemicals associated
24CML - Chemical Markup Language.Available in www.ch.ic.ac.uk/rzepa/cml/, accessed last time in 18-
11-2016
25THE IUPAC INTERNATIONAL CHEMICAL IDENTIFIER (INCHI).Available in https://iupac.org/
who-we-are/divisions/division-details/inchi/, accessed last time in 18-11-2016
26DSSTox.Available in https://datahub.io/dataset/dsstox, accessed last time in 30-11-2016
27DSSTox project.Available in www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database,
accessed last time in 30-11-2016
28U.S FOOD DRUG ADMINISTRATION.Available in www.fda.gov/default.htm, accessed last time in 30-
11-2016
29PACTF.Available in www.pharmainformatic.com/html/pact-f.html, accessed last time in 30-11-2016
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with diseases, toxic effects of some chemicals for the health of humans or animals, among others.
On the web page is available the list of all the databases that constitute TOXNET, with a brief
description of each one30.
PharmacoKinetics Knowledge Base (PKKB) is a free web repository that contains a larger
database extension with very relevant information concerning ADMET tests. This repository con-
tains data from about 1685 drugs covering various test properties, such as, solubility, intestinal
absorption, volume of distribution, urinary excretion, among others31.
ADMEdata is a web repository containing data sets obtained from different studies. The com-
plete database has 597 compounds and about 9500 data points that allow the creation of predictive
ADME models. This repository has available data sets on tests of absorption, distribution and also
metabolism32.
Super Toxic is a web repository that contains information about known toxic compounds
and uses that information to assess the property of unknown substances. Super Toxic database
provides several search options by name and also by properties, such as, molecular weight or
measured toxicity values. The use of these data enables the risk assessment of the new products to
be minimized and their subsequent toxicity effects33.
Cheminformatics is a web repository that contains links to several chemoinformatics pro-
grams as well as several data sets. All data sets are free for academic purposes. This web site
contains data sets on the combination of more than one ADMET properties, toxicity, molecules
that penetrate BBB, among others 34.
Sometimes, repositories only present the names of the molecules and it is necessary to get their
structure. ChemSpider is a free chemical structure database that allows structure search access and
has many data sources for more than 58 million structures35.
2.3 Data Mining
In recent times, there has been an exponential growth in the information to which people have ac-
cess through the Internet [26]. Most of the institutions (public and private), store computer data of
their activities, creating large data repositories [27]. Companies have monitored the development
of the technologies, and over the years have been collecting and storing a large amount of data
continuously. In the 1990s, particular attention was paid to these stored data. It was realized that
the data were being underutilized and that it could be an added value for the strategic positioning
of the companies. However, the high volume of data stored in disparate structures has quickly
30TOXNET.Available in www.nlm.nih.gov/pubs/factsheets/toxnetfs.html, accessed last time in 30-
11-2016
31PharmacoKinetics Knowledge Base.Available in http://cadd.suda.edu.cn/admet/v, accessed last time
in 15-01-2017
32ADMEdata.Available in www.admedata.com/, accessed last time in 15-01-2017
33Super Toxic project.Available in http://bioinf-services.charite.de/supertoxic/index.php?
site=home, accessed last time in 15-01-2017
34Cheminformatics.Available in http://cheminformatics.org/, accessed last time in 15-01-2017
35ChemSpider.Available in www.chemspider.com/, accessed last time in 21-01-2017
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become overwhelming. Thus, the need to create databases and database management systems
arose [26]. Today, society is commonly referred to as being in the "information age". With the
great expansion of the use of new technologies, the markets demand professionals to be prepared
for this evolution. So, there has been an increase in tools to organize and manage all the data,
allowing the discovery of information in databases which apparently did not exist or were hidden
[28]. Due to the great need for data analysis tools without limitations, researchers resort to ideas
and methods developed in Machine Learning36. This search for new ideas led to the emergence of
a new area of research, Knowledge Discovery in Databases (KDD), currently also known as Data
Mining (DM) [3, 26].
Often, the concepts of DM and KDD are used as synonyms. Knowledge Discovery in Databases
(KDD) is a non-trivial process of identifying, validating and recognizing data patterns that may
provide valid information by generating useful and unexplored knowledge about a specific database.
This process describes the extraction of knowledge from the data and generally consists of a set
of various steps such as data cleansing, data integration, data selection, data transformation, data
mining, evaluation of standards and finally, the evaluation of knowledge, as it is possible to see
in Figure 2.5. Data Mining is a step of the KDD process, and is at the heart of the process of
knowledge exploration. It is at this stage that the techniques and algorithms that will be used in
the problem are applied, in order to extract data models [29].
Figure 2.5: An overview of the steps that compose the KDD process. Extracted from [3].
Data Mining aim to extract useful regularities from long data archives in two possible ways,
directly in the form of "knowledge" - characterizing the relations of the variables of interest, or
indirectly - as functions that allow prediction, classification or representation of the regularities, in
the distribution of the data [26]. Data Mining in hospital databases and public health information
systems makes it possible to discover relationships so that a prediction of future trends can be
made, allowing a better characterization of the patient. However, some health professionals have
difficulty understanding the data. This can probably happen due to the high rate at which data is
generated, which leads to an inability of the human being to extract and interpret this data [27].
36This area develops computational models to acquire knowledge based on previous facts.
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Data Mining is one of the most promising technologies today [30]. It aims to find hidden rela-
tionships between data to allow predictions for the future. It is a process of extracting useful data
from large volume databases, which means, it consists of the discovery of interesting knowledge,
such as patterns, associations or anomalies [26].
Data Mining is considered as an extension of the traditional method of data analysis, since
it consists of several analytical techniques. DM is used in many areas, from the most traditional
to the most modern, due to the ease and speed of access to the data and the information needed.
It has applications in the field of marketing, science, medicine, telecommunications, financial
data analysis, retail industry, Adaptive Business Intelligence (ABI) among others. Thus, this may
be the solution to the data analysis problems that many organizations face daily. However, this
technology is still very recent, and so it is necessary to research to make it more efficient [31].
There are several processes that define and standardize the different phases and activities of
Data Mining. The CRISP-DM (Cross-Industry Standard Process of Data Mining) [32] is the most
used model due to the high information available in the literature and because it is currently con-
sidered the most accepted standard [30]. This is divided into 6 cyclic steps and the flow is not
unidirectional as can be seen in Figure 2.6.
The phases of CRISP-DM are:
1. Business understanding - this step is important for understanding the different organizations
that can use Data Mining, thus helping the next steps.
2. Data understanding - it is necessary to know the source from which the data came from,
who collected them, what they mean, etc. Thus, once the objectives are defined, knowledge
of the data is necessary.
3. Data preparation - data comes in various forms and formats. Due to the different possible
sources, it is likely that the data is not prepared for the application of Data Mining methods.
Data preparation can involve a number of activities, depending on the quality of the data.
4. Modelling - a model, in the area of Data Mining, is a computerized representation of real
observations. In this step DM algorithms are applied based on the intended objectives.
5. Assessment - this is considered the critical stage of the Data Mining process. It is necessary
the participation of experts and knowing of the business to do the evaluation. This phase is
specific to help determine if the model is valuable and what can be done with it. To test the
reliability of the models, some tests and validations must be performed. Indicators should
also be obtained to assist in the analysis of results, such as confusion matrix, correction
index, kappa statistic, mean absolute error, precision, F-measure, among others.
6. Deployment - in this step there is a need to organize and present knowledge in a way that the
client can use. It involves several steps such as planning, monitoring and maintaining the
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plan, producing the last report and reviewing the project. Usually, these steps are performed
by the client37 [30, 33].
Figure 2.6: Phases of CRISP-DM process. Extracted from37.
Data Mining tasks
Generally, Data Mining is classified according to its ability to perform different tasks [30]. These
tasks are very distinct as there are many types of patterns in a massive database. Thus, different
methods and techniques are needed to meet different types of patterns.
Depending on the patterns we are looking for, Data Mining tasks can be classified into classi-
fication, association rules discovery, clustering, outlier detection and regression [30, 34, 35].
Classification
Classification is one of the most common tasks and its final objective is to identify which class
a particular record belongs to (through the analysis of previous records) [30]. It is a supervised
learning method, that is, it uses sets that were previously classified to predict the classification of
the new observation [36].
Classification defines a set of models that can be used to classify new objects. The models
are constructed from a pre-analysis of the data set of a sample that possess objects classified in a
correct form. These models can be represented in several forms, such as, Decision Trees, Random
37CRISP-DM.Available in www.explore-thinking.com/bring-order-into-the-social-media-monitoring-process/,
accessed last time in 25-10-2016
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Forest, Naivy Bayes, rule-based, k-Nearest Neighbors (k-NN), Support Vector Machine (SVM),
among others [27, 30, 31, 34, 37].
Classification algorithms
Decision Trees: works as a tree-shaped flowchart, that is, it has the shape of an inverted tree that
has its root at the top and is divided successively into several branches. The input attributes
are represented by the inner nodes of the tree and each branch represents a possible result for
this test. The lower nodes are called sheet nodes and represent the classes that the algorithm
is attempting to predict38.
This method is quite simple to interpret, it does not require configuration parameters, it also
does not require much data preparation and it can deal with missing values. As disadvantage,
this algorithm can originate super-complex trees, causing overtting.
All decision tree algorithms follow a set of steps:
- Selection of an attribute A in order to divide;
- Subdivision of attribute A in disjoint subsets;
- A tree is returned with attribute A as a root and with a set of branches on the lower level.
Each branch will have a descending sub-tree;
There are several algorithms designed for the construction of decision trees: ID3,C4.5,CART
and CHAID. Different algorithms are distinguished by the criterion that decides which next
node to be explored and the type of test performed at each node inside the tree [35, 38].
In the classification experiments performed it was used the CART algorithm.
For the CART algorithm, the selection criterion used to choose the A node to be explored
is Gini Index or Gini impurity metric. The node having the least impurity is chosen and the
impurity is calculated by the formula:
GiniIndex( f ) =
J
∑
i=1
f i(1− f i) (2.1)
where, J represents the number of classes and fi corresponds to the fraction of items labeled
with class i.
As a general rule, the decision tree algorithm ends its recursion when all data examples have
the same label value. However, there are also other conditions that may lead recursion to
end: when there are less than a number of instances or examples in the current sub tree
(this problem can be adjusted through the parameter "minimum size for split"), when no
attribute achieves a given minimum gain, relative to the existing tree before that division (a
38Classification And Regression Trees for Machine Learning, by Jason
Brownlee, 2016. Available in http://machinelearningmastery.com/
classification-and-regression-trees-for-machine-learning/, accessed last time in 21-05-2017
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solution for this problem can be set via the "minimal gain parameter"), and lastly, when the
maximum depth is reached (this can be adjusted through the "maximal depth parameter")
[35, 38].
Random Forest: corresponds to a large number of decision trees. Each observation is fed into
each decision tree. The number of decision trees generated is specied by the programmer.
The resulting model is a voting model among all the generated decision trees. For exam-
ple, a certain attribute "x" belongs to class "1" if was predicted by most trees generated as
belonging to class "1" [35].
Each decision tree is generated in the same way as the decision trees specified in the previous
algorithm. The only difference is that for each division, random forest selects the node
from a random set of nodes, instead of being selected from among all available nodes to be
branched (decision trees algorithm) 39.
Naive Bayes: is an algorithm based on the Bayes’ theorem. This is a supervised learning algo-
rithm that assumes that the presence (or absence) of a given attribute is not related to the
presence (or absence) of any other attribute 40, [39].
Given a role = label ’C’ attribute of classes c1, c2, ..., cn and an attribute vector ’a’ cor-
responding to all other attributes, the conditional probability of a class ci can be defined
as:
P(C = ci|a) = P(C = ci)∗P(a|C = ci)
P(a)
(2.2)
Rule-based classification: has the structure -if- condition -then- conclusion and is sometimes
retrieved from a decision tree [27, 40]
k-NN: corresponds to a test of structural similarity between test and training objects. The lower
the distance, the more similar these compounds will be. This technique uses a space rep-
resentation of instances in order to classify different instances of unknown classes. More
specifically, k-NN has its training elements in space, each associated with the class to which
it belongs. In order to classify the test elements, it is necessary to verify the votes of the
nearest neighbors, and the new element is classified by the most frequent answers. If k = 1,
the element is classified with the class corresponding to its nearest neighbor (and so on for
the various values of k) [35].
39Random Forests Algorithm, Michael Walker, 2013. Available in www.datasciencecentral.com/
profiles/blogs/random-forests-algorithm, accessed last time in 21-05-2017
40Naive Bayesian, Dr. Saed Sayad. Available in www.saedsayad.com/naive_bayesian.htm, accessed last
time in 21-05-2017
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SVM: is a relatively recent technique but has been widely recognized for its results. This is a
supervised machine learning algorithm that is used both in classication and regression 41.
Given a set of training examples, each marked as belonging to one of two classes, the SVM
algorithm constructs a model that represents a number of examples with points in space.
These points are mapped so that the examples in each category are divided by a straight
line. Examples that belong to different classes should be represented as far as possible.
The new examples, present in the test file, are then mapped in the same space and predicted
as belonging to one of the two classes, according to the side of the line in which they are
placed. When data are not linearly separated, it is necessary for the SVM algorithm to resort
to the kernel function.
SVM’s main problem is the time it takes to train a model [22], [30].
Association rules discovery
Association rules discovery is a task responsible for most of the solutions that are used for pattern
discovery. The algorithms of association rules discovery aim to discover rules to quantify the
correlation between two or more attributes, thus allowing the understanding of the new models.
This correlation is commonly referred to as the association rule. This association rule reveals
whether the appearance of a set of objects in a database, is closely related to the appearance of
another set [27, 29]
Clustering
Clustering is a task that does not depend on the existence of pre-sorted data. Therefore, this
is an unsupervised learning technique that learns from observation and not from examples. A
successful cluster produces high-quality clusters to ensure that objects within a cluster are very
similar to each other, but very different from objects in other clusters. Once clusters are formed, the
objects are labelled and their common characteristics are summarized to form the class description.
This task is similar to classification, with the difference that in the classification, classes are pre-
defined and in clustering, classes are dynamically created based on the similarity between the
elements. Clustering can be used in several areas, such as, image processing, data analysis, pattern
recognition, among others. This task has some algorithms, the most common are k-Means and k-
Medoids [30, 31, 37, 40, 41].
Clustering algorithms
K-Means: is a method in which, in a data set, the algorithm selects randomly k records, each
representing a cluster. Then, for each record that remains, the similarity between it and the
41Understanding Support Vector Machine algorithm from examples (along with code),
by SUNIL RAY , 2015. Available in www.analyticsvidhya.com/blog/2015/10/
understaing-support-vector-machine-example-code/, accessed last time in 21-05-2017
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center of each cluster is calculated, and the object is placed in the cluster that has the greatest
similarity.
k-Medoids: is an algorithm that appears as a variation of the previous method. The main differ-
ence is that in this technique, instead of calculating the center of the cluster and to use it as
reference, the most central object of the cluster is used.
Partitioning and hierarchical methods generate clusters that are usually spherical. However,
in some cases this distribution may be denser and the results are not the most satisfactory.
Thus, density-based methods are emerging and allow for better results . Given an aleatory
set of points in space, it groups together points with many nearby neighbors, marking as
outliers the points that lie alone in low-density regions (whose nearest neighbors are too
far away). An example of an algorithm of this type is Density-Based Spatial Clustering of
Applications with Noise (DBSCAN) [30].
Outliers
Outliers are exceptions (data elements) that cannot be grouped into classes or clusters. Although
they may be considered as noise and discarded in some applications, in others may bring important
information and their analysis is quite significant [30, 31].
Regression
Regression is a supervised learning task, often compared to classification (classification groups
finite sets of discrete values and regression predicts continuous values). It is also used to find
out which independent variables are related to the dependent variable, and to understand this
relationship. Thus, regression consists in estimating the value of a given variable, by analyzing
other attribute values in the same item. The model obtained by regression can be represented in
the form of linear regression, logistic regression, among others [30, 31, 42]..
Regression algorithm
Linear regression: is used to estimate a relationship between two variables through the math-
ematical formula: Y = mX + b. For example, in a graph with a Y and an X axis, the
relationship between X and Y is a straight line [30, 31, 42].
Other algorithms: some of classification algorithms, such as Decision Trees, Random Forest,
SVM and k-NN, are also regression algorithms.
Data Mining tools
In order to facilitate the process of Data Mining, several useful tools have been developed. The
most popular ones are described throughout this section.
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Waikato Environment for Knowledge Analysis (WEKA): is a set of machine learning al-
gorithms for DM that was implemented in 1997 in New Zealand. It is a very popular
open source tool developed in Java (which allows it to be used on several platforms). This
software provides the necessary functionality to perform various tasks such as association
rules discovery, regression, clustering and has several algorithms inside each task42,43. The
WEKA system has a simple graphical interface and its biggest advantage is the fact that
it allows comparing the performance of different techniques, verifying which one has the
lower error rate [30, 43, 44, 45].
KNIME: is a tool that allows doing the analysis of patterns, predicting potential results in the data
and also discovering trends. This software is free and its graphical interface allows the user
to gather several nodes to perform the pre-processing, modelling, analysis and visualization
of data44, [46].
RapidMiner: is an open source tool that was developed in 2001. This platform provides an
integrated environment for machine learning, DM, between other areas. RapidMiner has
algorithms to construct models for predictive analysis and also enables the graphical visu-
alization of the results. This tool has the advantage of allowing that complex analyzes and
resulting forecasts can be integrated directly into the customer’s infrastructure, and also has
the advantage that it is rarely necessary to write codes, which makes it a very intuitive tool
[47].
R tool: in addition to being a scripting language, is also an integrated development environment
for statistical and graphical use. This is widely used for data analysis and provides a wide
range of statistical and graphical techniques (such as linear and nonlinear modeling, classi-
fication, clustering, among others). An important feature of this tool is the ease with which
mathematical symbols and formulas can be manipulated whenever necessary. However, it
has the disadvantage of its unfriendly interface45.
Evaluation metrics: classification
Before using a model, it is necessary to evaluate it by testing its behaviour with real data and
then doing its validation using good evaluation practices. For this, different metrics have been
proposed, each of which evaluates different characteristics of the data classifier [4, 48]. The main
characteristic of a classification system is that it can predict which class an object belongs to,
42"Mineração de dados com WEKA, Parte 1: Introdução e regressão".Available in www.ibm.com/
developerworks/br/opensource/library/os-weka1/, accessed last time in 25-10-2016
43Weka 3: Data Mining Software in Java.Available in www.cs.waikato.ac.nz/ml/weka/, accessed last time
in 25-10-2016
44Examining the KNIME open source data analytics platform.Available in http://
searchbusinessanalytics.techtarget.com/feature/Examining-the-KNIME-open-source-data-analytics-platform,
accessed last time in 25-10-2016
45R language.Available in www.r-project.org/about.html, accessed last time in 25-10-2016
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otherwise there is an error46,47. The performance of a classification system is calculated by the
ratio of the number of errors found to the total number of instances tested. Metrics play a crucial
role in selecting the best classifier during the training48, [4].
Data classification problems may be divided into binaries, multiclass, and multi-labelled clas-
sification.
Accuracy, Error rate, Precision, Recall, F-measure and AUC are the metrics addressed in this
report49, [4].
Accuracy: is one of the most used metrics to evaluate the generalization of classifiers, whether in
binary or multiclass classification problems. It is based on the proportion of correct predic-
tions for all instances, which means, its purpose is to estimate how often the classifier makes
the correct predictions. The main advantage of this metric is that it is easy to calculate and
easy to understand by users. The main disadvantages are that it does not differentiate classes
(positive or negative) and leads to poor values of discrimination (less rigor in choosing the
right solution).
Accuracy is defined as:
t p+ tn
t p+ f p+ tn+ f n
(2.3)
where, tp - true positive for C; tn - true negative for C; fp - false positive for C; fn – false
negative for C.
Error rate: like accuracy, also belongs to the most commonly used metrics and they complement
each other. This represents the proportion of errors committed in relation to the total set of
instances, and this percentage is used to evaluate the solution produced. Its main advantage
is the ease of performing the calculation. Error rate is defined as:
f p+ f n
t p+ f p+ tn+ f n
(2.4)
where, tp - true positive for C; tn - true negative for C; fp - false positive for C; fn – false
negative for C.
Precision: is used to identify which predictive items are true and so gives the ratio of ’tp’ to all
positive results. The precision and recall metrics have only one evaluation task (positive or
46Testing and Validation (Data Mining).Available in https://msdn.microsoft.com/en-us/library/
ms174493.aspx), accessed last time in 03-01-2017
47Turi Machine Learning Platform User Guide.Available in https://turi.com/learn/userguide/
evaluation/classification.html), accessed last time in 03-01-2017
48Classification Accuracy is Not Enough: More Performance Measures You Can
Use, Jason Brownlee, 2014.Available in http://machinelearningmastery.com/
classification-accuracy-is-not-enough-more-performance-measures-you-can-use/),
accessed last time in 03-01-2017
49Model Evaluation.Available in www.saedsayad.com/model_evaluation.htm), accessed last time in 03-
01-2017
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negative class), so do not have the possibility to choose the optimal solution. Usually, these
techniques are complementary and used together. Precision can be defined as:
t p
t p+ f p
(2.5)
where, tp - true positive for C; fp - false positive for C.
Recall: corresponds to the proportion of positive cases that are correctly identified, and can be
defined as:
t p
t p+ tn
(2.6)
where, tp - true positive for C; tn - true negative for C.
Area Under the Curve (AUC) and F-measure: are metrics also used for discrimination in
binary classification problems. The main advantage of AUC is its excellent effectiveness.
However, it has the disadvantage of high computational cost, specially when it is used in
multi-class classification problems. The AUC values represent the performance of a classi-
fier and the value 1 corresponds to a perfect classifier.
The AUC value can be calculated by:
Sp−np(nn+1)/2
np ∗nn (2.7)
where, Sp represents the sum of the all positive examples ranked, while np and nn means
the number of positive and negative examples respectively.
F-measure is defined as below:
2∗ p∗ r
p+ r
(2.8)
where, p - precision; r - recall.
Table 2.1 below presents a summary of the definition of the most used evaluation metrics.
Table 2.1: Metrics for classification evaluations. Adapted from [4].
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Metrics Evaluation focus
Accuracy Measures the ratio of correct predictions over
the total number of instances evaluated;
Error Rate Measures the ratio of incorrect predictions
over the total number of instances evaluated;
Precision Measures the positive patterns that are cor-
rectly predicted from the total predicted pat-
terns in a positive class;
Recall Measures the fraction of positive patterns that
are correctly classified;
F-Measure Represents the harmonic mean between recall
and precision values.
The degree of reliability of each metric is estimated with the confusion matrix [48, 49, 50, 51,
52]. Confusion matrix allows to define the four quantities already mentioned in the formulas of
each metric:
True Positives (tp): corresponds to the number of positive molecules predicted correctly;
True Negatives (tn): as the name implies, it corresponds to the number of negative molecules
predicted correctly;
False Positives (fp): corresponds to the number of negative molecules that are predicted to be
positive;
False Negatives (fn): corresponds to the number of positive molecules that are predicted to be
negative [51].
The confusion matrix simplifies the understanding of these concepts and is represented in the
Table 2.2.
Table 2.2: Example of a confusion matrix.
Evaluation methodologies: classification
In the process of developing a model, the evaluation phase is a crucial process and must be done
rigorously. This evaluation allows the verification of the behaviour of the models, and allows their
choice according to what has the best characteristics.
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Cross Validation is one of the methods of evaluating models in Data Mining50. It consists on
the evaluation of the general capacity of a model. This technique has several types:
Hold-Out method: consists of dividing the data set into two main subsets, training set and test
set (sometimes it is also divided into three subsets, adding the validation set). Figure 2.7
presents an example of this method. The training set is used in the building of predictive
models and in the train of the classifier. The validation set is used to evaluate the perfor-
mance of the model produced in the training phase, and may not occur in all modeling
algorithms. The test set enables to estimate the error rate of the classifier and also the future
performance of the model. The main advantage of this technique is that it presents indepen-
dent training and testing. On the other hand, it has the disadvantage of not using all available
data (performance evaluation may be very different) and depending on the way the training
/ testing division is done51.
Figure 2.7: An example of the Hold-Out method using 80% of the examples for training and 20%
for testing.
k-fold Cross Validation: is the most common and consists of dividing the data set into k parts
of approximately equal size. The model is built in all folds, but one is left out and is used to
test the prepared model while the others are used as training set. The main advantage of this
approach is the displaying of an accurate estimation of the performance of the model and
the disadvantages are overlapped training data, small samples of performance estimation
and underestimated performance variance52, 53.
In Figure 2.8 it is possible to see an example of k-fold Cross-Validation technique, with k=2.
In this example, data is divided into 2 and therefore, two models are built. For each model
half of the examples is used for training and the other half of the examples is used for testing.
Leave-One-Out Cross Validation: is a specific case of k-fold Cross Validation when k is equal
to the sample size (N), that is, equal to the number of instances in the data. An example
of this Cross-Validation method can be seen in Figure 2.9. The advantage of using this
50Cross Validated.Available in http://stats.stackexchange.com/questions/103459/
how-do-i-know-which-method-of-cross-validation-is-best, accessed last time in 03-01-2017
51Hold-Out method.Available in scott.fortmann-roe.com/docs/MeasuringError.html, accessed last
time in 03-01-2017
52Model evaluation, model selection, and algorithm selection in machine learning, Sebastian Raschka, 2016.Avail-
able in https://sebastianraschka.com/blog/2016/model-evaluation-selection-part3.html,
accessed last time in 03-01-2017
53k-fold.Available in https://pt.slideshare.net/hafidztio/l1penalization?smtNoRedir=1, ac-
cessed last time in 03-01-2017
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Figure 2.8: An example of the 2-fold Cross Validation method.
approach is that it provides an unbiased performance estimate. On the other hand has the
disadvantage of having a high computational cost and not allowing stratification54, 55.
Figure 2.9: An example of the specific case of Leave-One-Out Cross Validation method.
As it is possible to verify, this method uses only one of its examples for testing, and all other
examples as training.
Evaluation metrics: regression
There are several parameters that are considered when it comes to evaluate the regression models.
Root Mean Squared Error (RMSE) and Mean Absolute Error (MAE) are the metrics addressed in
this report.
Root Mean Squared Error: is a measure that provides the deviation between the observed
values and the predicted activity values. RMSE is often used and it makes an excellent
general purpose error metric for numerical predictions.
Root Mean Squared Error is mathematically defined as:
54How to Evaluate Machine Learning Algorithms, Jason Brownlee, 2013.Available in http://
machinelearningmastery.com/how-to-evaluate-machine-learning-algorithms/, accessed
last time in 03-01-2017
55Leave-One-Out method.Available in www.projectrhea.org/rhea/index.php/Leave-one-out_
Cross_Validation_Old_Kiwi, accessed last time in 03-01-2017
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√
1
N
N
∑
i=1
(yi− yˆi)2 (2.9)
where, y represents the values of experimental activity, yˆ symbolizes the expected activity
values and N represents the number of molecules.
Mean Absolute Error: represents the information about the average of the deviations obtained
in predicting activity.
1
N
N
∑
i=1
|yi− yˆi| (2.10)
where, y represents the values of experimental activity, yˆ symbolizes the expected activity
values and N represents the number of molecules [22, 53].
2.4 Ontologies
As the volume of data currently available is growing at a very large pace, it is necessary to use tech-
niques of data processing and organization. The same concepts and definitions can be interpreted
in different ways by the community. Thus, the need to create ontologies to standardize concepts
and create norms arose. Ontology is an information organization technique that has its structure
based on the description of concepts and semantic relationships between them56,57, [54, 55, 56].
The main objective of ontologies is to facilitate the sharing and reuse of information. For this to
be possible, it is necessary that the concepts present in the ontologies have a formal specification.
In 1997, Borst [57] described that "ontologies are defined as a formal specification of shared
conceptualization". From this definition, it is possible to understand that ontologies are very im-
portant in the various systems that aim to look for information coming from diverse communities,
such as the information contained online.
There are several areas in which ontologies can be used, such as information retrieval, natural
language processing, knowledge management, among others.
Their use brings some advantages such as to enable people to communicate about a particular
knowledge, to allow the expulsion of contradictions and inconsistencies in the representation of
knowledge and also to enable its developers to reuse knowledge bases, due to the formation of a
consensus vocabulary. In spite of the various applications and advantages of ontologies, these still
present some problems as the choice of the appropriate ontology for all the individuals or groups
related to some specific domain, there can be problems related to the ontology library, since each
one of ontologies could have been developed in a different context and there is also the problem
of the lack of papers describing the methodologies for its development [57, 58, 59, 60].
56Ontologies and Semantic Web.Available in www.obitko.com/tutorials/ontologies-semantic-web/
what-is-ontology.html), accessed last time in 09-01-2017
57Ontology, 2009.Available in http://tomgruber.org/writing/ontology-definition-2007.htm),
accessed last time in 09-01-2017
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Chemical ontologies
In the field of biology and chemistry, the amount of information available has been increasing
exponentially. Thus, a more efficient organization of this data is necessary through the filtration
process and posterior hierarchization of the concepts by computational methods. Thus, ontolo-
gies have been used to facilitate the organization of large volumes of data and allow a concise
hierarchical classification [57, 58].
Chemical Entities of Biological Interest (ChEBI) is an ontology that constitutes a database,
and that can be used for several attempts. It is available online for free58 and aims at grouping
chemical entities, such as, atoms and molecules. This ontology creates a hierarchical classification
of molecules based on their structural chemical characteristics, biological functions and system
interactions [57].
Hierarchical classification of molecules has several advantages, such as, allowing a compact
representation of generalized knowledge at the highest level (which facilitates user understanding)
and also plays an important role in useful predictions and predicting properties of new entities
[57, 58].
The use of ontologies in the chemoinformatics domain is very relevant because it allows a
better interpretation of biological mechanisms, which allows the detection of bioactivity patterns
associated with the chemical structure of the molecules59, [61, 62, 63].
Encoding ontologies
An ontology language is a formal language that is used to encode / save the ontologies. Currently
there is a big diversity of languages to formalise ontologies. In this report are addressed only the
most common60.
The languages of ontologies can be classified according to sintax and logic, and the most com-
mon of the two classes are Knowledge Interchange Format (KIF), Developing Ontology-Grounded
Methods and Applications (DOGMA), Resource Description Framework (RDF) and the Web On-
tology Language (OWL)60, [64].
KIF: provides the definition of objects, relationships, functions and it is easy to understand the
logic. The meaning of the expressions can be understood without needing the interpreter to ma-
nipulate these expressions [64].
DOGMA: is another language that is not restricted to a particular language. It has some properties
that distinguish it from other languages. It differs in its basis for the representations of knowledge
and in its specific duality in the interpretation between the level of language and the conceptual
level [64].
58www.ebi.ac.uk/chebi/
59Ontology, 2009.Available in http://tomgruber.org/writing/ontology-definition-2007.htm),
accessed last time in 09-01-2017
60Ontology language.Available in https://en.wikipedia.org/wiki/Ontology_language, accessed last
time in 21-01-2017
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RDF: is used for conceptual description or modelling of information implemented in web re-
sources. It uses various syntax notations and serialization data formats [64].
OWL: is the most known language and can include data as an interpretation of individuals and
a set of properties that relate them to each other. This language is used for the publication and
sharing of ontologies in the World Wide Web (WWW).
OWL was developed with the purpose of extending the existing vocabulary in the RDF lan-
guage (previously explained).
World Wide Web Consortium (W3C)61,62assumes three variants of this language: OWL Lite,
OWL DL and OWL Full, according to the levels of expressiveness. It is considered an essential
technology for the future implementation of the semantic web and has therefore been used to
search tools, formal fundamentals and language extensions [64].
2.5 Related work
When it comes to starting a project, it is extremely important to review the related work. It is
important to know what has already been done, what methods and tools have been used, the
problems faced, the progress made, the results achieved, what can be improved and what has not
yet been done but can lead to great progress in the area. After the research, it was verified that the
Data Mining algorithms have already been used in several situations for prediction studies.
Predictive studies
Prevention of cancer is a public health issue of unquestionable importance. The US National Tox-
icology Program (NTP) conducts chemical rodent bioassays to help identify substances that may
have harmful effects in humans. However, these trials are costly and result in a time-consuming
process, which has led to an urgent need for the construction of models that propose molecular
mechanisms for various health problems such as carcinogenesis, mutagenesis and toxicity testing
[65, 66, 67].
Inductive Logic Programming (ILP) 63 tools were used for that predictive studies. They pro-
duce rules that are more concise and accurate than attribute-based algorithms. Most of these
studies used the PROGOL ILP tool [65, 66, 67].
iLogCHEM
Another related work is iLogCHEM tool. iLogCHEM is an application that was designed to
predict a property of interest through the structural information in a set of drugs [68]. Differ-
ent compounds having similar structures usually exhibit the same pharmacological activity. The
61Is the main organization of standardization of the World Wide Web.
62www.w3.org/Consortium/
63Inductive Logic Programming is an area of Artificial Intelligence (AI) that studies the construction of theories from
examples and prior knowledge. This is at the intersection of machine learning and logic programming.
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Structure-Activity Relation (SAR) studies the path to make the drug more active through the anal-
ysis of structural relationships.
The iLogCHEM system aims to provide the analysis of molecules, through Data Mining tools,
in an easy and transparent way for the user [69]. This system relies on three basic principles:
only refines fragments that appear in the database, filter duplicates and perform efficient homo-
morphism tests.
Initially the system receives a data set from molecules already tested and identifies a set of
patterns that are characteristic in the molecules that have activity.
The main problem in the construction of systems is the description of molecules. However,
finding a discriminating component often reduces to the problem of finding a Common Maximum
Substructure (CMS), that is, finding a pattern with the maximum number of atoms and bonds
that is present in several molecules in the database introduced. The first approaches to look for
common subframes are based on ILP, that uses first-order logic and has a powerful representation
language, but is inefficient when using large databases. In this system the Aleph ILP tool was used
with atoms and bonds as background knowledge [69].
Although its representation is not as specialized as other systems, the iLogCHEM tool has
several advantages. An advantage is that the system can use the high number of search algorithms
that are implemented in ILP [68]. An important feature of the iLogCHEM tool is the possibility
of adding extra information, which will facilitate the search process of the appropriate model.
Thus, the user can choose which chemical structures he wants to detect in the molecules and then
facilitate the understanding of the models. This important feature is achieved through the ability of
ILP to accept background knowledge for rule discovery. In this system, the models are presented
to the user through the visualization of the molecule and the pattern, using the Visual Molecular
Dynamics (VMD) tool [25, 68].
The structure of the molecules is strictly related to their therapeutic effect. However, some-
times the drugs have the desired activity but not the required amount and other times lead to
adverse effects. These problems can be solved in the RDD. So, the drug design process starts with
a molecule that already has some activity, and then, are made modifications to improve it. How-
ever, there is the disadvantage of obtaining a large set of similar molecules. Thus, iLogCHEM
has a solution. This system uses Tanimoto’s distance (the user can choose the limit value for the
distance used) to filter the pairs of similar molecules and retain only the most representative ones
[68].
Other related work included an extension to the iLogChem tool. As mentioned above, this
tool builds models using Data Mining algorithms that allow to determine whether a molecule is
active or not. The already tested molecules are explored and patterns are found within them that
allow inferred about its activity, both molecules and patterns can be visualized graphically and the
specialist can also introduce restrictions on the creation of new rules.
This extension allows the inserted data set to have more than one format and not only provides
the activity or inactivity of the molecule but also allows the created models to predict the ADMET
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tests. In addition to the ILP system previously used by iLogChem, this extension uses Weka, that
is another Data Mining tool [68, 70].
All the investigations and works carried out are important for those who have an interest in
the area. It is important to make tests, use different methods and tools or continue studies already
done, to achieve the objectives and bring the best living and health conditions to the humanity
[68].
2.6 Chapter summary
In this chapter, it were introduced the basics concepts necessary to understand the project.
It was explained the RDD process that allowed the understanding of the problems of cost and
time that are associated to this process, and that are the object of study of the work.
The concept of Data Mining was addressed, as well as its tasks, tools and other properties,
which lead, after a detailed analysis, to the choice of the most appropriate tool to use in the work.
The methodologies and metrics to evaluate the experiments that were used in the study were
established.
The most relevant web repositories for the study were identified.
Ontologies and their languages were described in the last part of the chapter. It was possible to
understand their importance for the organization of large amounts of data, to standardize concepts
that lead to a more precise sharing of knowledge and to enrich data sets.
It was also mentioned some related work to the subject of study.
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Chapter 3
Experimental evaluation
In this chapter we first make a contextualization of the work and then we describe the steps in-
volved in data preparation. The second part is divided in two sections: Toxicity experiments and
Blood-Brain Barrier (BBB) penetration experiments. These two sections include a description of
the data sets, the data pre-processing and the experiences performed.
3.1 Work plan contextualization
The dissertation work corresponded to a set of Data Mining experiments in order to answer the
two research questions stated in Chapter 1.
Figure 3.1 presents the general block diagram of the tasks that were done in the dissertation
work.
Figure 3.1: Brief explanation of the work that was developed.
As previously mentioned, the main objective of the work was to use Data Mining tools in order
to improve ADMET tests.
The first step of the work was to choose a set of molecules previously tested in animals, which
were downloaded from web repositories (in this case, DSSTox and Cheminformatics).
The following actions took place in the pre-processing stage. The data were prepared in dif-
ferent ways to obtain an adequate data set.
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After pre-processing, the data undergoes an enrichment stage where added information was as-
sociated with each molecule. This extra information was computed using Open Babel and PaDEL
tools.
The Data Mining tool chosen to carry out the experiments was RapidMiner due to its simple
interface. We have used the educational version, since it allows free and unrestricted number of
lines in the data sets (only for students and teachers).
As this work is prospective in nature, we have investigated the quality of several algorithms to
assess which provided the best results.
For classification studies we have used: SVM, k-NN, Decision Trees with CART and Random
Forest with CART algorithms.
In the regression study we have experimented Linear regression, SVM and k-NN algorithms.
3.2 Data preparation
As mentioned before, nowadays there is a large amount of data available and accessible. Data
Mining is one of the approaches that can be used to explore this data. For this exploration, it is
advisable to carry out some steps in order to prepare data, such as:
1. Data cleansing: when it comes to large databases, it is normal for inconsistent, incomplete
or erroneous data to exist. For this reason, it is necessary to treat this data in order to avoid
its influence on the results;
2. Data integration: since the data can have different origins, it is necessary to integrate it to
avoid some problems, such as identification problems (the same concept can be designated
differently), and thus to have a repository unique and consistent;
3. Data transformation: it depends on the desired objectives, some algorithms work only with
categorical values and others with numerical values, it may be necessary to normalize the
data (size the attributes on the same scale), among other transformations;
4. Data reduction: this phase aims to reduce the volume of data while maintaining the repre-
sentativeness of the original data. It may include the elimination of attributes that are not
of interest to the study that is being performed, leading to greater efficiency of Data Mining
algorithms [71].
3.3 Cases studies
3.3.1 Toxicity Experiments
The first approach investigated was with toxicity data. Several experiments were made with these
data, but the general plan of the study is represented in Table 3.1.
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Experiments with toxicity data were performed with the original data and also with tanimoto-
filtered data. On the right side of the Table 3.1 the scheme in which the original toxicity data was
used is shown. On the left side one can see the scheme in which the data was previously filtered
using a tanimoto coefficient.
Tanimoto coefficient filters similar pairs of molecules and retains only the most representative
one. This coefficient was used to test if there was an improvement in the results when removing
pairs of molecules with similar structure.
Table 3.1: Methodology for toxicity experiments.
Data set
Distributed Structure-Searchable Toxicity (DSSTox) is a project that researches information
about the toxicity of some molecules and chemical structures (already explained in section 2.2).
One of the data sets used for toxicity experiments was Carcinogenic Potency Database Sum-
mary (CPDBAS)1. Carcinogenic Potency corresponds to the level of toxicity present in molecules
related to the chances of cancer.
The other data set used was the EPA Fathead Minnow (EPAFHM)1. U.S. EPA Mid-continental
Ecology Division (MED) generated this database with the aim of developing a system to predict
acute toxicity from the chemical structure based on the mode of action.
Data pre-processing
The original files were in SDF format, so the first step of the experiment consisted of using the
OpenBabel tool to obtain the SMILES format of the molecules. Figure 3.2 represents the graphical
interface of the OpenBabel software.
In order to apply a classifier, we need to define / compute the attributes to enrich the data
set. This was enriched with molecular descriptors. As previously mentioned, these descriptors
constitute a set of attributes that characterize the molecules.
The set of molecular descriptors was calculated using the PaDEL Descriptors software. As
already mentioned in section 2.2, this platform contains a total of 1875 descriptors (1444 1D
and 2D descriptors, and 431 3D descriptors). Figure 3.3 represents the graphical interface of the
PaDEL software.
1www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database
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Figure 3.2: Representation of the graphic interface of the OpenBabel software.
Figure 3.3: Representation of the graphic interface of the PaDEL software.
After calculating the 1D and 2D descriptors, the CPDBAS data set contained information
on 1230 (586 molecules classified as ’active’ and 644 classified as ’inactive) compounds and
1444 attributes, and EPAFHM data set contained information on 617 (580 molecules classified as
’active’, 34 classified as ’inactive’ and 3 had inconclusive results) compounds and 1444 attributes.
Some attributes representing molecular descriptors were removed because they contained a
large number of missing values (they were not applicable to all molecules).
After removing missing values, CPDBAS data set had 1230 examples and 506 attributes, and
EPAFHM data set had 617 molecules and 1212 attributes.
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In EPAFHM data set we have also removed the molecules with inconclusive results, and there-
fore, the final data set contained 614 molecules.
The main reasons for the reduction of attributes are the decrease of the training time of each
algorithm, and also an overall improvement of the model. Infrequent attributes can lead the model
to make noise-based decisions and thus lead to system overfitting.
Classification
Without feature selection
In this first experiment, the classification process was performed without feature selection, which
means that all the attributes were considered and there was no pre-selection. The flow diagram of
the global classification process is represented in Figure 3.4.
Figure 3.4: Classification process without feature selection.
The first step of the process was to open the data file through the "Retrieve" operator. This
operator aims to read a file from the data repository.
The next operator used was the "Set Role" to change the target role of the ’Class’ (information
extracted from DSSTox) attribute from "regular" to "label" because it was necessary to execute the
classification algorithm. Thus, the classifier predicted this attribute. Figure 3.5 shows a sample
of the output of this operator. When the attribute ’Class’ = active - means that the molecule has
toxic characteristics, when the attribute ’Class’ = inactive - means that the molecule has no toxic
properties.
Then we have used the "Cross Validation" operator. This operator automatically subdivides
into the training and test procedures, as can be seen in Figure 3.6.
The training process contains the chosen classification operator. The testing process contains
the "Apply Model" operator and the "Performance" operator.
"Apply Model" receives on the first port the model that contains all the information about the
data with which it was trained and on the second port receives the test file.
The "Performance (Binominal classification)" operator was used to evaluate the model, in this
case, was used to get the values of Accuracy, Precision, Recall and F-measure metrics.
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Figure 3.5: Sample of the output of the "Set Role" operator for CPDBAS data set.
Figure 3.6: Sub-process of "Cross Validation" operator.
With feature selection
The first experiment was repeated with feature selection, which means, with a pre-selection of the
best attributes. The flow diagram of the classification process with feature selection is represented
in Figure 3.7.
As in previous experience, the first step was to open the data file through the "Retrieve" opera-
tor. The next operator used was the "Set Role". Once again this was used to change the target role
of the ’Class’ attribute from "regular" to "label".
Next, the "Normalize" operator was applied to all attributes of the database. This step causes
all attributes to be transformed so that they all vary between the same values. In this way, at-
tributes with large values are prevented from having a greater weight in the prediction of each data
example.
Afterwards, feature selection was made and two operators were used.
"Weight by Correlation" operator generates a weight for each attribute of the database, and this
weight corresponds to the correlation between each input attribute and the label. The greater the
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Figure 3.7: Classification process with feature selection.
weight of an attribute, the more relevance it has, and therefore it is taken in greater consideration
to solve the problem. We show in Figure 3.8 a sample of the output of the "Weight by Correlation"
operator.
Figure 3.8: Sample of the output of the "Weight by Correlation" operator for CPDBAS data set.
"Select by Weights" operator selects only the "k" attributes with the highest weight (in this
case, k = 10).
According to this operator, the top ten attributes of CPDBAS data set (in descending order of
relevance) are:
MDEN-23- molecular distance edge between all secondary and tertiary nitrogens;
MATS1e- moran autocorrelation - lag 1 / weighted by Sanderson electronegativities;
ATSC1e- centered Broto-Moreau autocorrelation - lag 1 / weighted by Sanderson electronegativities;
AATS3i- average Broto-Moreau autocorrelation - lag 3 / weighted by first ionization potential;
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AATS1i- average Broto-Moreau autocorrelation - lag 1 / weighted by first ionization potential;
AATS3e- average Broto-Moreau autocorrelation - lag 3 / weighted by Sanderson electronegativities;
AATS2i- average Broto-Moreau autocorrelation - lag 2 / weighted by first ionization potential;
IC0- information content index (neighborhood symmetry of 0-order);
nN- number of nitrogen atoms;
C2SP3- singly bound carbon bound to two other carbons2.
It is important to note that these ten attributes were selected (by the operator) as the best for
the four classification algorithms used in the experiment.
Then we have used the "Cross Validation" operator. As mentioned before, this operator is
automatically subdivided into the training and test procedures.
The training process contains the chosen classification operator. The testing process contains
the "Apply Model" operator and the "Performance (Binominal classification)" operator. This last
one was used to get the values of Accuracy, Precision, Recall and F-measure.
The other toxicity experiment was similar to the previous one but for the EPAFHM data set.
The flowchart is the same, and the top ten attributes (in descending order of relevance) chosen
by the "Select by Weights" operator are:
LipinskiFailures- number failures of the Lipinski’s Rule Of 5;
ATS8v- broto-Moreau autocorrelation - lag 8 / weighted by van der Waals volumes;
WPATH- broto-Moreau autocorrelation - lag 8 / weighted by van der Waals volumes;
ATS8p- broto-Moreau autocorrelation - lag 8 / weighted by polarizabilities;
EE_D- estrada-like index from topological distance matrix;
SpMax_D- leading eigenvalue from topological distance matrix;
SpAD_D- spectral absolute deviation from topological distance matrix;
ATS7v- broto-Moreau autocorrelation - lag 7 / weighted by van der Waals volumes;
SpDiam_D- spectral diameter from topological distance matrix;
ECCEN- a topological descriptor combining distance and adjacency information2 .
In the same way, it was also obtained the top ten for EPAFHM data filtered with tanimoto
coefficient:
GGI8- topological charge index of order 8;
2www.scbdd.com/padel_desc/descriptors/
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ATS8v- broto-Moreau autocorrelation - lag 8 / weighted by van der Waals volumes;
ZMIC1- Z-modified information content index (neighborhood symmetry of 1-order);
ATS8m- broto-Moreau autocorrelation - lag 8 / weighted by mass;
WPATH- weiner path number;
GGI9- topological charge index of order 9;
GGI7- topological charge index of order 7;
ATS8p- broto-Moreau autocorrelation - lag 8 / weighted by polarizabilities;
LipinskiFailures- number failures of the Lipinski’s Rule Of 5;
EE_D- estrada-like index from topological distance matrix3.
Once again, it is important to note that these ten attributes were selected (by the operator) as
the best for the four classification algorithms used in the experiment.
3.3.2 Blood-Brain Barrier penetration Experiments
Experiments with BBB penetration data were performed using two Data Mining tasks, regression
and classification (the difference between these two has already been explained in section 2.3).
The global work plan used for regression task can be seen in Table 3.2:
Table 3.2: Methodology for regression experiments of BBB penetration data set.
The work plan used for the classification is similar to the regression, but with classification
algorithms. This work plan is represented in Table 3.3:
Data set
Cheminformatics is a web repository that contains links to several data sets (already presented
in section 2.2). The Blood-Brain-Barrier penetration data4 used were the same as Liu et al. [72]
3www.scbdd.com/padel_desc/descriptors/
4www.cheminformatics.org/
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Table 3.3: Methodology for classification experiments of BBB penetration data set.
used for their penetration studies. That studies were performed for regression task. However, the
methodologies of evaluation of the models were different, and therefore it was not possible to
compare their results with the results obtained in this experience.
Data pre-processing
The original data set was in SDF format, so for the application of the regression task it was
necessary to originate the SMILE format of molecules (using OpenBabel) and calculate molecular
descriptors (again using the PaDEL Descriptor software).
This data set contained 57 compounds as training set and 13 as test set. After the calculation
of molecular descriptors (1D+2D), the data set got 1444 attributes.
After removing the missing values, BBB penetration data set got 1356 attributes.
For the classification task, the pre-processing described earlier was the same.
The original BBB penetration data is a regression problem [72], which means that the class is
numeric. To apply the classification task it was necessary to transform the class into binominal.
The histogram of the activity of the molecules of the BBB penetration data was used to know
where to divide the two classes. The point where there was a more pronounced difference between
the points on the left side and the points on the right side was chosen.
A complete division and a division with a gray zone in the middle was made. This gray
area was left to sharpen the boundary between the two classes (molecules with high capacity to
penetrate the BBB and molecules with low capacity to penetrate the BBB), and thus help the
classifiers.
This histogram is represented in Figure 3.9.
After analyzing the obtained histogram, a division was made to separate the values of the
molecules and then create the label attribute for classification.
For division without the gray area:
values of activity ≥ 0 - classified as high;
values of activity < 0 - classified as low.
For division with the gray area:
values of activity ≥ 0.5 - classified as high;
values of activity < 0 - classified as low.
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Figure 3.9: Representative histogram of the activity of molecules.
This gray zone comprises the values ≥ 0 and < 0.5.
When the attribute ’class’ = high - means that the molecule has high capacity to penetrate
through BBB, when the attribute ’class’ = low - means that the molecule has low capacity to
penetrate through BBB.
Figure 3.10 contains a sample of ’class’ attribute.
Figure 3.10: Sample of the file corresponding to the attribute ’class’.
Regression problem
The first experience with the BBB penetration data was performed for the regression. The flow
diagram was constructed and is represented in the Figure 3.11.
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Figure 3.11: Linear Regression process.
The first step of the project was to open the data file through the "Retrieve" operator. This
operator aims to read a file from the data repository. In this case, the database used had two files
(test and training) and so it was necessary to read both.
The next operator used was the "Set Role" to change the target role of the ’logBBexpt’5 at-
tribute from "regular" to "label" in order to execute successfully the regression algorithm. Thus,
this regression algorithm predicted this attribute. Since there were two input data files, this opera-
tor was applied to both.
Feature selection was performed and the operators used were "Weight by Correlation" and
"Select by Weights".
"Select by Weights" operator selects only the "k" attributes with the highest weight (in this
case, k = 10).
According to this operator, the top ten attributes for BBB penetration data (in descending order
of relevance) are:
nHBAcc- number of hydrogen bond acceptors (using CDK HBondAcceptorCountDescriptor algorithm);
TopoPSA- topological polar surface area;
nHBd- count of E-States for (strong) Hydrogen Bond donors;
nHBDon- number of hydrogen bond donors (using CDK HBondDonorCountDescriptor algorithm);
nHBAcc_Lipinski- number of hydrogen bond acceptors (using Lipinski’s definition: any nitrogen; any
oxygen);
nBondsD- number of double bonds;
5Corresponds to the logarithm of the ratio of the concentration of a drug in the brain and in the blood (this ratio is
measured at equilibrium) and this value is an index of BBB permeability. logBBexpt means logBB experimental value.
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nBondsD2- total number of double bonds (excluding bonds to aromatic bonds);
nHBint2- count of E-State descriptors of strength for potential Hydrogen Bonds of path length 2);
nN- number of nitrogen atoms;
SHBd- sum of E-States for (strong) hydrogen bond donors6.
The "Multiply" operator was used to copy the input (weights) to multiple outputs (in this case
for training and testing data).
Then the chosen regression algorithm was applied in order to do the numerical prediction.
Next, the "Apply Model" operator was used. This receives on the first port the training model
that contains all the information about the data with which it was trained and on the second port
receives the test file.
Finally, the "Performance (Regression)" operator was introduced. This was used to evaluate
the model, in this case, to get the values of Root Mean Squared Error and Mean Absolute Error.
Classification problem
This classification experiment was performed for the two different data sets. A complete data set
and another with the gray area (already explained in data pre-processing).
The flow diagram of the classification process was constructed and is represented in the Fig-
ure 3.12. This flowchart is similar to the regression one but with a classification algorithm and
with the "Performance (Classification)" operator.
Figure 3.12: Classification process for BBB penetration data.
As in the classification for toxicity experiments, this flowchart was repeated for the four clas-
sification algorithms (SVM, k-NN, Decision Trees and Random Forest).
According to "Select by weights" operator, the top ten attributes for BBB penetration data
without gray area (in descending order of relevance) are:
6www.scbdd.com/padel_desc/descriptors/
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maxHBd- maximum E-States for (strong) Hydrogen Bond donors;
minHBd- minimum E-States for (strong) Hydrogen Bond donors;
MLFER_A- overall or summation solute hydrogen bond acidity;
SHBd- sum of E-States for (strong) hydrogen bond donors;
nHBd- count of E-States for (strong) Hydrogen Bond donors;
nHBDon- number of hydrogen bond donors (using CDK HBondDonorCountDescriptor algorithm);
TopoPSA- topological polar surface area;
nHBAcc_Lipinski- number of hydrogen bond acceptors (using Lipinski’s definition: any nitrogen; any
oxygen);
ETA_dEpsilon_D- a measure of contribution of hydrogen bond donor atoms;
nHBDon_Lipinski- number of hydrogen bond donors (using Lipinski’s definition: Any OH or NH. Each
available hydrogen atom is counted as one hydrogen bond donor)7.
By the same way, according to "Select by weights" operator, the top ten attributes for BBB
penetration data with gray area (in descending order of relevance) are:
ETA_Epsilon_2- a measure of electronegative atom count;
hmax- maximum H E-State;
AATS0e- average Broto-Moreau autocorrelation - lag 0 / weighted by Sanderson electronegativities;
ETA_dEpsilon_C- a measure of contribution of electronegativity;
ETA_dPsi_A- a measure of hydrogen bonding propensity of the molecules;
ETA_Psi_1- a measure of hydrogen bonding propensity of the molecules and/or polar surface area;
ETA_Epsilon_4- a measure of electronegative atom count;
Mse- mean atomic Sanderson electronegativities (scaled on carbon atom);
MAXDN- maximum negative intrinsic state difference in the molecule (related to the nucleophilicity of
the molecule). Using deltaV = (Zv-maxBondedHydrogens) /(atomicNumber-Zv-1);
AATSC0e- average centered Broto-Moreau autocorrelation - lag 0 / weighted by Sanderson electronegativities7.
The selection of attributes by this operator is important because it helps to understand which
descriptors most significantly influence the activity of the molecule.
7www.scbdd.com/padel_desc/descriptors/
Chapter 4
Results and discussion
This chapter presents the global results of the experiments. Toxicity experiments were performed
using a classification task and the results of the experiment are described in the first part of the
chapter. The penetration experiments were performed with two tasks, regression and classification,
and the results obtained are described in the second part of the chapter. A discussion / evaluation
of these results is also made. The metrics used to evaluate the results were Accuracy, Recall,
Precision and F-measure for classification, and Root Mean Squared Error and Mean Absolute
Error for regression.
4.1 Toxicity Experiments
Toxicity experiments had as objective the use of classification algorithms to predict the behavior
of the molecules for toxicity. For the accomplishment of this task, the classication algorithms used
were:
- Support Vector Machines (tested with kernel Radial Basis Function (RBF) adjusted in the
parameters);
- k-NN (the parameter of k-NN (k) was tested for the values of 1, 3 and 5. The most satisfactory
parameter was k = 5 and so was used in the several experiments);
- Decision tree with CART;
- Random Forest with CART (the number of trees used was equal to 10).
Classification
Without feature selection
In this experiment no feature selection was performed and all attributes were considered. For
a better understanding of the tables, it is important to note that the first column represents the
evaluation metrics: Accuracy, Precision (active) - corresponds to the precision of the active class
(molecules with toxic activity) -, Recall (active) - corresponds to the recall of the active class -,
Precision (inactive) - corresponds to the precision of the inactive class (molecules without toxicity
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activity) -, Recall (inactive) - corresponds to the recall of the inactive class - and F-measure. The
other four columns represent the four classification algorithms used.
Table 4.1 shows the results obtained for CDPBAS data set without feature selection, for all the
evaluation metrics and the four different classification algorithms. This experiment was performed
using 10-fold Cross Validation (k = 10).
Table 4.1: Results of the classification experiment (without feature selection) for CPDBAS data
set.
Evaluation metrics SVM k-NN Decision Tree Random Forest
Accuracy 52.28% (+/- 1.41%) 56.99% (+/- 4.82%) 50.98% (+/- 1.86%) 51.95% (+/- 2.94%)
Precision (active) 48.57% 54.77% 47.81% 46.03%
Recall (active) 2.90% 55.80% 31.74% 4.95%
Precision (inactive) 52.38% 59.08% 52.44% 52.27%
Recall (inactive) 97.20% 58.07% 68.48% 94.72%
F-measure 68.08% (+/- 0.99%) 58.65% (+/- 3.72%) 52.70% (+/- 21.05%) 67.35% (+/- 2.25%)
Taking advantage of the Decision Tree algorithm not be an algorithm of the black box type, a
survey was made regarding the molecular descriptors chosen as root of the decision tree.
Inspection to the generated decision tree for the original CPDBAS data set, revealed that the
best descriptor (tree root) was MDEN-23. This descriptor means the molecular distance edge
between all secondary and tertiary nitrogens1.
After analyzing the values obtained for all the metrics, we verified that the classification al-
gorithm k-NN was the one that obtained more satisfactory prediction results, with an accuracy of
56.99% for CPDBAS data set.
With feature selection
Table 4.2 shows the results obtained for CPDBAS data set with feature selection, for all the
evaluation metrics and the four different classification algorithms. This experiment was performed
using 10-fold Cross Validation (k = 10).
Table 4.2: Results of the classification experiment (with feature selection) for CPDBAS data set.
Evaluation metrics SVM k-NN Decision Tree Random Forest
Accuracy 60.81% (+/- 2.93%) 58.54% (+/- 4.97%) 52.28% (+/- 0.37%) 53.41% (+/- 2.49%)
Precision (active) 67.45% 55.72% 44.44% 62.26%
Recall (active) 34.30% 63.14% 0.68% 5.63%
Precision (inactive) 58.69% 61.84% 52.33% 53.02%
Recall (inactive) 84.94% 54.35% 99.22% 96.89%
F-measure 69.33% (+/- 3.04%) 57.70% (+/- 6.23%) 68.52% (+/- 0.34%) 68.55% (+/- 0.77%)
Observing the generated decision tree for the CPDBAS data set, we found that the best de-
scriptor (tree root) was AATS3i. This descriptor means average Broto-Moreau autocorrelation -
lag 3 / weighted by first ionization potential1.
1www.scbdd.com/padel_desc/descriptors/
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After analyzing the values obtained for all the metrics, we verified that the classification al-
gorithm SVM was the one that obtained more satisfactory prediction results, with an accuracy of
60.81% for CPDBAS data set.
Comparing the results obtained by the two experiments (without and with feature selection),
we note that accuracy values are higher when feature selection is performed, which was expected,
since a pre-selection of the best attributes was made. Figure 4.1 shows a comparison of this two
experiments.
Figure 4.1: Results of the accuracy for CPDBAS data set (without and with feature selection) and
the four classification algorithms under study.
Through the graph it is possible to verify that the data that obtained the best accuracy was
CPDBAS with feature selection when performed with SVM algorithm. The least favorable result
was obtained for CPDBAS without feature selection data set when performed with Random Forest
algorithm.
As previously mentioned, an overall analysis of the graph allows to conclude that the four
algorithms work better when the feature selection is performed.
Table 4.3 presents the global accuracy averages (without feature selection and with feature
selection) for the four classification algorithms.
Table 4.3: Results of the accuracy averages for each of the algorithms used.
Algorithm Accuracy average
SVM 56.55%
k-NN 57.77%
Decision Tree 52.12%
Random Forest 52.20%
Briefly, the algorithm k-NN was the one that achieved the best accuracy (57.77%) followed by
SVM, with an accuracy of 56.55%.
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As previously mentioned, the CPDBAS data set was filtered with tanimoto coefficient. How-
ever, there were no changes to the original file, which proved that the molecules are sufficiently
differentiated and therefore the results of the experiment were not presented.
To compare the original and tanimoto-filtered data, it was used EPAFHM data set. After
filtering with tanimoto coefficient, this data set was composed of 396 compounds (instead of the
original 617).
Table 4.4 presents the results obtained by the SVM algorithm for EPAFHM data sets. Once
again, this experiment was performed using 10-fold Cross Validation (k = 10).
Table 4.4: Results of the classification experiment (with feature selection) with SVM algorithm
for the two EPAFHM data sets.
Evaluation metrics EPAFHM EPAFHM (tanimoto filtered)
Accuracy 94.31% (+/- 1.05%) 94.46% (+/- 1.85%)
Precision (active) 94.45% 94.42%
Recall (active) 99.83% 100.00%
Precision (inactive) 0% 100%
Recall (inactive) 0% 8.33%
F-measure — 15.38%
Table 4.5 presents the results obtained by the k-NN algorithm. Once again, this experiment
was performed using 10-fold Cross Validation (k = 10).
Table 4.5: Results of the classification experiment (with feature selection) with k-NN algorithm
for the two EPAFHM data sets.
Evaluation metrics EPAFHM EPAFHM (tanimoto filtered)
Accuracy 94.96% (+/- 2.34%) 94.21% (+/- 3.35%)
Precision (active) 96.92% 95.56%
Recall (active) 97.76% 98.39%
Precision (inactive) 55.17% 53.85%
Recall (inactive) 47.06% 29.17%
F-measure 50.45% 37.84%
Table 4.6 shows the results obtained by the Decision Tree algorithm. Once again, this experi-
ment was performed with 10-fold Cross Validation (k = 10).
Table 4.6: Results of the classification experiment (with feature selection) with Decision Tree
algorithm for the two EPAFHM data sets.
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Evaluation metrics EPAFHM EPAFHM (tanimoto filtered)
Accuracy 95.45% (+/- 1.73%) 95.22% (+/- 2.83%)
Precision (active) 96.15% 95.84%
Recall (active) 99.14% 99.19%
Precision (inactive) 68.75% 72.73%
Recall (inactive) 32.35% 33.33%
F-measure 44.00% 45.71%
Observing the generated decision tree for the original EPAFHM data set, we found that the
best descriptor (tree root) was ATS8v. This descriptor means the broto-Moreau autocorrelation -
lag 8 / weighted by van der Waals volumes2.
Looking at the generated decision tree for EPAHFM tanimoto-filtered data set, we saw that the
best descriptor (tree root) was GGI8. This descriptor means the topological charge index of order
82.
Table 4.7 shows the results obtained by the Random Forest algorithm. Once again, this
experiment was performed using 10-fold Cross Validation (k = 10).
Table 4.7: Results of the classification experiment (with feature selection) with Random Forest
algorithm for the two EPAFHM data sets.
Evaluation metrics EPAFHM EPAFHM (tanimoto filtered)
Accuracy 95.28% (+/- 1.13%) 94.70% (+/- 2.37%)
Precision (active) 95.12% 95.12%
Recall (active) 98.97% 99.46%
Precision (inactive) 64.71% 71.43%
Recall (inactive) 32.35% 20.83%
F-measure 43.14% 32.26%
After analyzing the previous tables for, we saw that the data set that had a higher accuracy
value (95,45%) was the original EPAFHM when performed with Decision Tree algorithm. So, it
is also possible to note that the data filtered with tanimoto coefficient had slightly lower accuracy
values than the original data.
The graph represented in the Figure 4.2 shows a comparison of classification task for EPAFHM
original and EPAFHM tanimoto-filtered .
Through the graph it is possible to verify that the data that obtained the best accuracy was
EPAFHM original data set.
It is normal that the original data set presents better results than tanimoto-filtered data set,
because the first one has more similar molecules. By removing similar molecules, the classification
problem becomes more complicated.
The filtering with the tanimoto coefficient aims to obtain more realistic results.
2www.scbdd.com/padel_desc/descriptors/
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Figure 4.2: Results of the accuracy for the two EPAFHM data sets and the four classification
algorithms.
4.2 Blood-Brain Barrier penetration Experiments
Regression problem
This experiment was carried out with the objective of predicting the behavior of the molecules
(high penetration capacity or low penetration capacity) in the process of Rational Drug Design.
For the accomplishment of this task, the algorithms used were:
- Linear Regression;
- Support Vector Machines (it was adjusted in the parameters for ’nu-SVR svm type’ in order
to be used for regression task);
- k-NN (the parameter of k-NN (k) was adjusted for k = 5).
The results of the regression experiment with Linear regression algorithm are shown in the
Table 4.8.
Table 4.8: Results of the regression experiment with Linear regression algorithm for BBB pene-
tration data set.
Evaluation metrics BBB penetration
Root Mean Squared Error 0.779
Mean Absolute Error 0.671
The results of the regression experiment with SVM algorithm are shown in the Table 4.9.
Table 4.9: Results of the regression experiment with SVM algorithm for BBB penetration data
set.
Evaluation metrics BBB penetration
Root Mean Squared Error 0.610
Mean Absolute Error 0.453
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The results of the regression experiment with k-NN algorithm are shown in the Table 4.10.
Table 4.10: Results of the regression experiment with k-NN algorithm for BBB penetration data
set.
Evaluation metrics BBB penetration
Root Mean Squared Error 0.649
Mean Absolute Error 0.468
After analyzing the obtained values, it is possible to verify that the best results for the two
evaluation metrics are obtained when using SVM algorithm (RSME = 0.610 and MAE = 0.453).
Classification problem
As mentioned before, the regression task was converted into a classification task. Once again, for
the accomplishment of this experiment, the classication algorithms used were:
- Support Vector Machines (tested with kernel Radial Basis Function (RBF) adjusted in the
parameters);
- k-NN (the parameter of k-NN (k) was tested for the values of 1, 3 and 5. The most satisfactory
parameter was k = 5 and so was used in the several experiments);
- Decision tree with CART;
- Random Forest with CART (the number of trees used was equal to 10).
Without gray area
For a better understanding of the table, it is important to note that the first column represents
the evaluation metrics: Accuracy, Precision (low) - corresponds to the precision of the low class
(molecules with low capacity to penetrate BBB) -, Recall (low) - corresponds to the recall of the
low class -, Precision (high) - corresponds to the precision of the high class (molecules with high
capacity to penetrate BBB) -, Recall (high) - corresponds to the recall of the high class - and
F-measure. The other four columns represent the four classification algorithms used.
Table 4.11 shows the results obtained for BBB penetration data set (without gray area), for all
the evaluation metrics and the four classification algorithms.
Table 4.11: Results of the classification experiment (without gray area) for Blood-Brain Barrier
penetration data set.
Evaluation metrics SVM k-NN Decision Tree Random
Forest
Accuracy 69.23% 69.23% 61.54% 61.54%
Precision (low) 80.00% 100.00% 77.78% 77.78%
Recall (low) 80.00% 60.00% 70.00% 70.00%
Precision (high) 33.33% 42.86% 25.00% 25.00%
Recall (high) 33.33% 100.00% 33.33% 33.33%
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Looking at the generated decision tree for the BBB (without gray area) data set, we verified
that the best descriptor (tree root) was maxHBD. This descriptor means the maximum E-States for
(strong) Hydrogen Bond donors 3.
By observing the table, it is possible to verify that the algorithms that obtained the best per-
formance were k-NN and SVM with an accuracy value of 69.23% for BBB penetration data set
without gray area.
With gray area
Table 4.12 shows the results obtained for BBB penetration data set (with gray area), for all the
evaluation metrics and the four classification algorithms.
Table 4.12: Results of the classification experiment (with gray area) for Blood-Brain Barrier pen-
etration data set.
Evaluation metrics SVM k-NN Decision Tree Random
Forest
Accuracy 90.91% 72.73% 81.82% 81.82%
Precision (low) 90.91% 100.00% 100.00% 100.00%
Recall (low) 100.00% 70.00% 80.00% 80.00%
Precision (high) 0% 25.00% 33.33% 33.33%
Recall (high) 0% 100.00% 100.00% 100.00%
After observing the generated decision tree for the BBB (without gray area) data set, we saw
that the best descriptor (tree root) was AATS0e. This descriptor means the average Broto-Moreau
autocorrelation - lag 0 / weighted by Sanderson electronegativities4.
By observing the table it is possible to verify that the algorithm with the best performance was
SVM with an accuracy value of 90.91% for BBB penetration data set with gray area.
Comparing the two data groups, it is possible to verify that the BBB penetration data with the
gray area (accuracy = 90.91%) produced more promising results than the data without the gray
area (accuracy = 69.23%).
Figure 4.3 shows a comparison of the accuracy for the two data sets considered and the four
algorithms used.
Once again, it can be seen in the bar graph that for all algorithms, BBB penetration data set
with gray area was the one with the best accuracy (90.91%) for SVM algorithm.
As the best result was obtained for the BBB penetration data set with gray area for the SVM al-
gorithm, the experiment was repeated using the "Cross Validation" operator to evaluate the model.
This experiment was performed using 10-fold Cross Validation (k = 10).
The flow diagram applied was the same as for toxicity experiments and the results are pre-
sented in Table 4.13.
Table 4.13: Results of the classification experiment (with gray area) with SVM algorithm.
3www.scbdd.com/padel_desc/descriptors/
4www.scbdd.com/padel_desc/descriptors/
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Figure 4.3: Accuracy for the four algorithms under study.
Evaluation metrics BBB penetration
Accuracy 96.00% (+/- 8.00%)
Precision (low) 95.12%
Recall (low) 100.00%
Precision (high) 100.00%
Recall (high) 81.82%
F-measure 90%
By observing the table it is possible to verify that the accuracy result (accuracy = 96.00%) was
superior to the result obtained when pre-dividing the training and test set (accuracy = 90.91%).
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Chapter 5
Conclusions and Future work
In this chapter the conclusions of the work are presented and the results of the research are com-
mented, as well as a proposal for future work.
5.1 Satisfaction of results
This work was motivated by the increasing appearance of diseases and the need to develop drugs
(in the shortest possible time) to combat them. Research and development of new drugs is con-
stantly evolving due to the effort of the pharmaceutical industry and to scientific development
made at research institutions to bring better products to solve health problems.
A major hurdle in the development of a new drug is time (about 5-12 years) and the very high
costs. When the process refers to the design of drugs for the Central Nervous System (CNS) can
take even longer (up to 16 years). Informatics, and more specifically Data Mining technology may
help to mitigate those hurdles. Based on historical information on pre-clinical trials results, Data
Mining can build predictive models to estimate important features of the developed drugs, saving
money and time by reducing / avoiding those pre-clinical tests.
The main objective of this dissertation was to asses how useful Data Mining methods and algo-
rithms can be for the reduction of the Rational Drug Design process (more properly the ADMET
tests phase). To meet this goal, it was first necessary to conduct a study of the various concepts
associated with RDD and DM tools and algorithms that would be very useful for predicting drugs
efficacy.
In order to answer the two research questions stated in section 1.2, two case studies were
carried out. The first case study involved the realization of a classification experiment using two
data sets downloaded from DSSTox database.
The first experiment corresponded to toxicity experiments. We have used four classification
algorithms: SVM, k-NN, Decision Tree and Random Forest. The best results were obtained for
the k-NN algorithm (accuracy = 57.77%). However, this value was not very promising. This
experience was performed without feature selection, and then with feature selection (pre-selection
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of the attributes). With a comparative analysis of the results obtained it was possibly to verify that
the use of feature selection improved the performance of the models.
The second experiment used Blood-Brain Barrier penetration data. These experiments were
performed for the regression and classification tasks. For regression it were used three algorithms:
Linear regression, SVM and k-NN algorithms. The best results (lowest errors) were obtained for
the SVM algorithm (RMSE = 0.610 and MAE = 0.453). Classification was also performed using
the same four algorithms of the first experiment. We have considered two data sets, one complete
(without gray area) and another considering a gray area between the two classes (high and low).
Analyzing the results obtained, the best results were obtained for the data set with gray area for
SVM algorithm (accuracy = 90.91%).
In response to the research question H1 (stated in section 1.2), the results suggest that Data
Mining tool can be really useful to improve the drug design process. However, there are still many
gaps that need to be addressed and improved.
Regarding the research question H2, it was not fully answered since the only additional in-
formation we used were the 1D and 2D molecular descriptors. It would be interesting to add
information from 3D molecular descriptors, but it was not possible because the software could not
calculate these descriptors.
This dissertation revealed the interest of using Data Mining tools and methods to aid in the
Rational Drug Design process and the results obtained are encouraging for the continuation of this
line of research.
5.2 Future work
A proposal to improve the model would be the inclusion of ontologies (described in section 2.4)
as data enrichment. Thus, the inclusion of ontologies would be useful to verify if the addition
of chemical information improves the performance of Data Mining algorithms by helping the
generalization process.
Another interesting approach would be to compare the prediction results for different oper-
ators of feature selection (pre-selection of attributes) in order to verify if it would influence the
performance of the model.
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